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High-efficacy subcellular micropatterning of
proteins using fibrinogen anchors
Joseph L. Watson1, Samya Aich1, Benjamı́ Oller-Salvia1, Andrew A. Drabek2,3, Stephen C. Blacklow2,3, Jason Chin1, and Emmanuel Derivery1
Protein micropatterning allows proteins to be precisely deposited onto a substrate of choice and is now routinely used in cell
biology and in vitro reconstitution. However, drawbacks of current technology are that micropatterning efficiency can be
variable between proteins and that proteins may lose activity on the micropatterns. Here, we describe a general method to
enable micropatterning of virtually any protein at high specificity and homogeneity while maintaining its activity. Our method
is based on an anchor that micropatterns well, fibrinogen, which we functionalized to bind to common purification tags. This
enhances micropatterning on various substrates, facilitates multiplexed micropatterning, and dramatically improves the on-
pattern activity of fragile proteins like molecular motors. Furthermore, it enhances the micropatterning of hard-to-
micropattern cells. Last, this method enables subcellular micropatterning, whereby complex micropatterns simultaneously
control cell shape and the distribution of transmembrane receptors within that cell. Altogether, these results open new
avenues for cell biology.
Introduction
Micropatterning, also known as molecular printing, is the pro-
cess by which molecules are precisely deposited onto a substrate
of choice with micrometer resolution. Micropatterning is now
routinely used in all areas of biomedical research; for example,
in DNA microarrays, which have been around for decades and
rely on surfaces being printed one spot at a time (Bumgarner,
2013). Decades of photolithography technology led to the advent
of parallelized techniques for the affordable and straightforward
manufacturing of protein micropatterns on a variety of sub-
strates (Braunschweig et al., 2009; Falconnet et al., 2006). This
led to breakthroughs in biology, allowing researchers, for ex-
ample, to print cell adhesion proteins to constrain cell shape and
thus reveal the physical basis of cell polarity (Théry et al., 2006)
and spindle orientation during mitosis in cultured cells (Théry
et al., 2007). Concomitantly, the ability to print purified proteins
onto glass brought better control in in vitro reconstitution
studies, which strengthened our understanding of the dynamics
of cytoskeleton contractility (Reymann et al., 2012) as well as
the physiology of cytoskeletal polymers (Schaedel et al., 2019;
Aumeier et al., 2016). Finally, it was recently demonstrated that
electron microscopy grids could be micropatterned with cell
adhesion molecules (Toro-Nahuelpan et al., 2020; Engel et al.,
2019). The ability, therefore, to constrain the position and shape
of cells on grids is poised to solve the decade-old problem that
cells adheremuchmore efficiently to electron-impermeable grid
bars than electron-permeable carbon mesh.
Subtractive micropatterning by photolithography offers an
efficient and convenient method to generate protein micro-
patterns on any substrate. In this technique, the substrate is first
uniformly coated with an antifouling agent such as polyethylene
glycol (PEG; Falconnet et al., 2006) that blocks nonspecific
protein binding. This homogenous coat is then precisely etched
by photoscission using a deep UV light source and a quartz
photomask (Azioune et al., 2009) to allow specific adsorption of
the protein of interest. While broadly adopted, this method has
the inconvenient feature that each time one wants to make a
novel micropattern, a newmask has to be manufactured, adding
cost and time to the scientific process. As noted early on with
photobleaching-based techniques (Waldbaur et al., 2012; Bélisle
et al., 2009), using a microscope instead of a mask to project the
illumination micropattern has the major advantage that spatial
light modulators, such as digital micromirror devices (DMDs),
can be used to shape the illumination pattern at will. In addition,
using amicroscope de facto enablesmultiplexedmicropatterning
of multiple proteins (Bélisle et al., 2009), because the micro-
patterned protein can be imaged and the subsequent illumi-
nation micropattern precisely aligned with it. Multiprotein
micropatterning is muchmore tedious to achieve with masks or
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protein stamps due to difficulties in alignment (Eichinger
et al., 2012). Importantly, while deep UV is not compatible
with glass-based microscope optics, Fink et al. (2007) found
that micropatterning of PEG-coated coverslips could be ach-
ieved with regular UV light with a benzophenone photosen-
sitizer. Later elegant work by Strale et al. (2016) integrated all
these developments (microscope/DMD/photosensitizer/UV)
into a pioneering technique they termed light-induced mo-
lecular adsorption (LIMAP), which they demonstrated allows
convenient multiprotein micropatterning in a commercial
microscope.
While micropatterning offers tremendous possibilities for
biomedical research, a potential limitation of the technology is
the highly variable micropatterning efficiency of different pro-
teins. In particular, micropatterning selectivity (how much
protein adsorbs to the micropatterned compared with the non-
patterned region) and micropatterning homogeneity (how the
adsorption density varies within the micropattern) vary greatly
between proteins (see also Fig. 1 and Fig. S3). For instance, if a
given cell type requires a key extracellular protein to adhere to
the substrate, but that protein does not micropattern efficiently,
this cell type currently cannot be used in micropatterning as-
says. This variability between proteins is evenmore problematic
when micropatterning multiple proteins because it implies that
the different proteins will not necessarily bemicropatterned at a
consistent density. For complex micropatterning experiments,
such as testing the effects of opposing gradients of signaling
molecules, variable and inhomogeneous adsorption efficiencies
are thus a problem. Furthermore, while LIMAP-mediated mul-
tiplexed micropatterning offers unprecedented avenues for bi-
ology, it may bring additional problems. In particular, because of
the sequential nature of the micropatterning process, nonspe-
cific binding between successive micropatterns is possible,
where the second protein binds to the first micropattern if it has
not been completely quenched (a phenomenon we refer to as
cross-adsorption in this paper). In addition, the buffers and re-
active oxygen species (ROS) needed for LIMAP micropatterning
may not be optimal for maintaining the activity of proteins, so
while a protein might micropattern well, it might have lost its
activity by the time the user starts the experiment. Another
general source of activity loss when micropatterning is that the
direct adsorption of a protein onto the surface may induce un-
folding. All these limitations may either discourage researchers
from doing such complex experiments or force them to perform
long and painstaking optimizations of their micropatterning
process.
Here, we describe a general method to enable micro-
patterning of virtually any protein at a high specificity and
homogeneity. Our technology relies on a protein anchor that
micropatterns well, fibrinogen, which is functionalized to
recognize tags commonly used in protein purification, or that
can be added to already purified proteins. We show that this
quantitatively improves micropatterning of hard-to-micro-
pattern proteins on various substrates. In particular, we
demonstrate robust micropatterning of Con A, which thereby
enhances the micropatterning of hard-to-micropattern cells,
such as Drosophila cells. Furthermore, we show that our
technology provides an advantage for LIMAP-mediated multi-
protein micropatterning as, by design, not only does it allow for
all proteins to be micropatterned with similar homogeneity and
low nonspecific binding, it also shields proteins of interest from
any harm induced by the micropatterning process because they
are bound to the fibrinogen-anchor micropatterns after said
process. We also demonstrate that our technology allows the
control of the subcellular localization of membrane receptors
by simultaneously micropatterning cell adhesion proteins and
receptor ligands at high density. Altogether, we hope that our
contribution will facilitate micropatterning experiments and
open new avenues for biological research.
Results
We started by comparing the micropatterning efficiency of two
proteins broadly used for micropatterning, NeutrAvidin
(Aumeier et al., 2016; Schaedel et al., 2019; Portran et al., 2013)
and fibrinogen (Godinho et al., 2014; Azioune et al., 2009; Carpi
et al., 2011 Preprint). Except for Fig. 5, all micropatterns in this
study were obtained following the LIMAP protocol (Strale
et al., 2016) using a UV projector in a fluorescence micro-
scope (see Fig. S1 A for design) and the photosensitizer
(4-benzoylbenzyl)trimethylammonium bromide (BBTB; see
Materials and methods for one-step synthesis). To quantitatively
compare micropatterns throughout this paper, we evaluated
both micropattern selectivity (that is, howmuch protein adsorbs
to the micropatterned compared with the non-patterned region)
and micropattern homogeneity (that is, how the adsorption
density varies within the micropattern; see also Materials and
methods). As seen in Fig. 1, A and B, both the specificity and the
homogeneity of fibrinogen micropatterns are quantitatively
higher than equivalent NeutrAvidin micropatterns on polylysine
(PLL)-PEG–coated glass. As micropatterning is an adsorption
process, its efficiency is expected to vary according to the buffer
composition and according to changes in protein folding and
surface charges. Accordingly, we found that fibrinogen micro-
patterning is quantitatively improved in low-salt carbonate
buffer compared with PBS buffer (Fig. S1, B and C), consistent
with the known propensity of fibrinogen to precipitate in the
presence of salts. For this reason, all micropatterns in this paper
were generated in carbonate buffer (see Materials andmethods).
Importantly, fibrinogen displays remarkably low binding to non-
micropatterned PLL-PEG substrates (see Fig. S1, E and F; and Ma-
terials and methods): the amount of fibrinogen-ATTO488 wrongly
going onto the unpatterned PLL-PEG is only 0.40 ± 0.06% (mean ±
SEM; n = 8) that of the amount of fibrinogen-ATTO488 going
to its intended micropattern (0.66 ± 0.04% for fibrinogen-
Alexa647; n = 8). In other words, it is not that fibrinogen
binds everywhere, although better on the micropatterned
region, but rather that fibrinogen binds nearly exclusively to
the intended micropatterned region.
The intrinsic properties of fibrinogen also facilitate multi-
protein patterning. One key advantage of using the LIMAP
protocol within a microscope (Strale et al., 2016) is that it en-
ables straightforward multiprotein micropatterning, as the user
can both image one micropattern and, in the same instrument,
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readily align a second micropattern with respect to this micro-
pattern (ad infinitum). However, a potential issue is cross-
adsorption, where the second protein binds to the first protein
pattern. This can have two origins: either the second protein
binds to the first, or the first pattern was not completely
saturated by the first protein (or not subsequently efficiently
quenched), and thus the second protein can adhere there. Fi-
brinogen combines two advantages to alleviate these issues: (1)
soluble fibrinogen does not bind to micropatterned fibrinogen,
and (2) fibrinogen micropatterns can be efficiently quenched
Figure 1. High specificity and selectivity of fibrinogen micropatterning on PLL-PEG surfaces. (A) Fibrinogen-Alexa546 (50 µg/ml) and NeutrAvidin-
Dylight-550 (50 µg/ml) were micropatterned on PLL-PEG–coated glass using LIMAP with identical UV exposure and micropattern shape. After washing, red
fluorescence of the micropatterns was imaged by TIRF microscopy (TIRFM) using identical settings (left and middle). Alternatively, a higher dynamic range
lookup table was applied to the image on the right. (B) Quantification of the effects seen in A. Mean ± SEM of the selectivity and homogeneity (see Materials
andmethods). Statistics were performed using a Mann–Whitney rank-sum test. n, number of micropatterns measured. Fibrinogen quantitatively micropatterns
better than NeutrAvidin. (C) Scheme illustrating the different steps for sequential multiplexed micropatterning of three fibrinogens labeled with different
fluorophores (ATTO488, Alexa546, and Alexa647). (D) Multiplexed micropatterning of fibrinogen-ATTO488, Alexa546, and Alexa647 (50 µg/ml) using the
scheme depicted in C onto PLL-PEG–coated glass. Note that there is high specificity of the fibrinogen for their specific micropattern and minimum overlap
between the three fluorescent fibrinogens. (E) Quantification of the effects seen in D. The fluorescence of each fibrinogen was measured on the three
successive micropatterns and normalized to the intensity of their respective micropattern. Mean ± SEM. Statistics were performed using a one-way ANOVA
test followed by a Tukey post hoc test (P < 0.0001). n, number of micropatterns measured. Note that the amount of fibrinogen deposited onto the nonintended
micropatterns is minimal. Scale bars, 10 µm. n.s., not significant.
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with respect to fibrinogen (that is, soluble fibrinogen binds very
little to a quenched fibrinogen micropattern). To highlight these
properties, we thought to conduct sequential micropatterning of
fibrinogen labeled with three different fluorescent dyes: ATTO488,
Alexa546, and Alexa647 (Fig. 1 C). As seen in Fig. 1 D, all three fi-
brinogens adhere to their intended micropatterns, with minimal
cross-adsorption to the other patterns. Quantification revealed that
the amount of the second micropatterned protein, fibrinogen-
Alexa546, wrongly going onto the fibrinogen-ATTO488 pattern is
only 1.3 ± 0.05% (mean ± SEM; n = 12) of the amount going to its
intended pattern (see Fig. 1 E and Materials and methods).
Similarly, the amount of the third micropatterned protein,
fibrinogen-Alexa647, going to the wrong fibrinogen-ATTO488
or fibrinogen-Alexa546 patterns is minimal (0.7 ± 0.04% and
3.0 ± 0.3%, respectively, compared with the amount going to its
intended pattern; mean ± SEM; n = 12). Similar results were
obtained in sequential patterning of two (not three) fibrinogens
(Fig. S1, D–F).
We thus thought to exploit the inherent highmicropatterning
efficiency of fibrinogen to improve the micropatterning of
hard-to-micropattern proteins by conjugating them together.
Fibrinogen would thus act as the “anchoring” moiety, ensuring
that both micropatterning selectivity and homogeneity are high
and reproducible, while the protein of interest would provide
the “specificity” part, bringing the function required for the
experiment. This would also potentially improve accessibility,
and thereby activity, of the micropatterned protein, as not all of
the micropatterned protein would be facing the glass, which
may occur with direct micropatterning due to potential pre-
ferred orientation of protein deposition. Constraining protein
orientation would also mitigate potential surface-induced protein
unfolding. Fibrinogen is an ideal anchoring moiety for this as it is
commercially available in gram scales, is easy to work with, and
contrary to other commonly available proteins like BSA, precip-
itates natively with minute amounts of ammonium sulfate, a
property we could exploit to facilitate the separation of function-
alized products (see Materials and methods). We thus established
robust protocols for the biochemical functionalization of fibrinogen,
allowing it to be conjugated to virtually any protein of interest, as
well as permitting its binding to commonly used purification tags.
The conjugation method relied on the modification of
fibrinogen-exposed amines with a heterobifunctional cross-linker
that enabled conjugation with the target protein in a two- or three-
step procedure (see Fig. S2 and Materials and methods). In par-
ticular, we derived fibrinogen-GFP, fibrinogen–Con A (a lectin that
binds to insect cells; Rogers et al., 2002), fibrinogen-NeutrAvidin
(Fig. S2 A) to bind to biotinylated targets, fibrinogen–GFP-binding
peptide (GBP) to bind to GFP-tagged proteins (GBP is a nanobody
against GFP; Fig. S2 B; Rothbauer et al., 2008) and fibrinogen-
biotin (Fig. S2 C) to bind to streptavidin/NeutrAvidin fusions, as
well as to biotinylated targets using a NeutrAvidin "sandwich"
(fibrinogen-biotin::NeutrAvidin::biotinylated protein of interest).
Importantly, since fibrinogen contains numerous exposed amines,
it can be functionalized with multiple molecules. For instance, bi-
otin and ATTO490LS can be combined (fibrinogen-biotin-AT-
TO490LS) to micropattern biotinylated targets while at the same
time facilitating micropattern alignment by fluorescence
microscopy (see below). Note that these conjugation protocols
are general and apply to virtually any protein of interest.
Furthermore, these optimized protocols are straightforward,
use commercially available chemicals, and do not require any
specialized biochemistry equipment such as fast protein liquid
chromotography (FPLC).
As a proof of concept, we compared the micropatterning ef-
ficiency of a biotinylated target, BSA-biotin-Alexa647, through
either NeutrAvidin or fibrinogen-NeutrAvidin micropatterns.
This is a more relevant situation than just comparing the
micropatterning efficiency of fibrinogen-NeutrAvidin versus
NeutrAvidin, as what matters for experiments is the density of
micropatterned biotin-binding sites, which is not necessarily
the same as the density of micropatterned NeutrAvidin. As it is
always the same fluorescent protein being micropatterned, in
addition to determining the micropattern selectivity and ho-
mogeneity, we also estimated the amount of protein being
specifically bound to the micropattern from the fluorescence
intensity. As seen in Fig. 2, A and B, fibrinogen-NeutrAvidin
provides a fourfold improvement of the selectivity and homo-
geneity of micropatterned biotinylated targets, as well as the
13-fold improvement of the amount of protein being specifically
micropatterned. This was true for all fibrinogens; see, for in-
stance, fibrinogen-GFP offering higher selectivity, homogene-
ity, and amount of micropatterned protein than GFP alone
(Fig. 2 C; see also Fig. 2 D for quantification). Importantly, while
all experiments described until now were performed on PLL-
PEG–coated glass, the fibrinogen toolkit described here also
improves micropatterning on other commonly used substrates,
such as PEG-silane (Aumeier et al., 2016; Schaedel et al., 2019;
Portran et al., 2013); see Fig. S3.
We then thought to apply our technology to multiprotein
patterning. As mentioned above, sequential micropatterning
using LIMAP has three potential issues: (1) lack of homogeneity
between micropatterns due to the high variability of micro-
patterning between proteins, (2) cross-adsorption between
successive micropatterns because of incomplete quenching, and
(3) potential activity loss due to inappropriate buffers and/or
ROS generation. An additional issue is that while being able to
image a micropattern in the microscope to align the next one is a
major advantage of the technique, this requires the first mi-
cropatterned protein to be fluorescent. However, fluorescent
derivatives of proteins are not necessarily as active as their
unlabeled counterparts: for instance, we found that fluorescent
NeutrAvidin (NeutrAvidin–Dylight-550), while micropatterning
fine on fibrinogen-biotin, displayed a more than sixfold reduc-
tion in its ability to bind to biotinylated targets compared with
unlabeled NeutrAvidin (Fig. S3). Doping the unlabeled protein to
micropattern with some other fluorescent protein as a tracer is
not a solution either, because, as seen in Fig. 1, micropatterning
efficiencies widely differ between proteins, so the fluorescent
tracer will not necessarily be a reliable proxy for the amount of
unlabeled protein to be micropatterned.
The fibrinogen toolkit described here could address all these
limitations at once. First, it would ensure that micropatterning
homogeneity is similar for all micropatterned proteins, as it is
always the same protein anchor that is micropatterned
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Figure 2. Fibrinogen anchors improves selectivity and homogeneity of micropatterns on PLL-PEG surfaces. (A) NeutrAvidin, NeutrAvidin-DyLight-550,
NeutrAvidin mixed with fibrinogen, or NeutrAvidin fused to fibrinogen (Fibrinogen-NeutrAvidin) were micropatterned on PLL-PEG–coated glass using LIMAP
with identical UV exposure, micropattern shape, and protein concentration (50 µg/ml). After micropattern quenching and washing, BSA-biotin-Alexa647 (5 µg/
ml) was added for 5 min. The sample was then washed, and BSA-biotin-Alexa647 fluorescence was imaged by TIRFM. Two different dynamic ranges for
visualization were used for each sample (top versus bottom line) so that each lane could be represented with the same dynamic range. (B)Quantification of the
amount of protein bound to the micropattern (left), micropattern selectivity (middle), and homogeneity (right) in the sample presented in C (mean ± SEM).
Statistics were performed using a one-way ANOVA test followed by a Tukey post hoc test after log10 transformation of the data (P < 0.001). Fibrinogen-
NeutrAvidin enhances significantly the selectivity and the homogeneity of BSA-biotin-Alexa647 micropatterns. (C) GFP and fibrinogen-GFP were micro-
patterned on PLL-PEG–coated glass using LIMAP with identical UV exposure, micropattern shape, and protein concentration (50 µg/ml). After washing, GFP
fluorescence was imaged by TIRFM. (D) Quantification of the amount of protein selectively bound to the micropattern (left), as well as micropattern selectivity
(middle) and homogeneity (right) in the sample presented in C (mean± SEM). Statistics were performed using a Student’s t test (after log10 transformation of
the data for left and middle panels). The selectivity and homogeneity of fibrinogen-GFP micropatterns are significantly better than those of GFP alone. n,
number of micropatterns measured. Scale bars, 10 µm. n.s., not significant.
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(fibrinogen). Second, sequential micropatterning of different fi-
brinogen “flavors” is extremely efficient with minimal cross-
adsorption (see above; Fig. 1, C–E; and Fig. S1, D–F). Third, fi-
brinogen anchors functionalized against common purification
tags would enable one to first micropattern all the anchors, then
add the proteins of interest in their buffer of choice as the last step
of the sample preparation just before the actual experiment starts
(Fig. 2 A), therefore ensuring that the activity of the proteins of
interest is conserved. Last, each nonfluorescent fibrinogen anchor
can be doped with trace amounts of fluorescent fibrinogen for
micropattern alignment purposes without the risk that these trace
amounts might affect the micropatterning efficiency of the fi-
brinogen anchor. This last issue can also be alleviated by fluo-
rescently labeling fibrinogen anchors (Fig. 4, Fig. 6, and Fig. 7).
As a proof of concept, we micropatterned two proteins, GFP
and biotin-BSA-Alexa647, using fibrinogen-GBP and fibrinogen-
NeutrAvidin anchors, respectively (Fig. 3 A). As seen in Fig. 3 B,
fibrinogen anchors enable reliable micropatterning of these
two proteins. Cross-contamination between the two proteins is
quantitatively little: the amount of GFP wrongly going onto the
biotin-BSA-Alexa647 micropattern is only 5.0 ± 0.3% (mean ±
SEM; n = 7) of the amount going to its intended micropattern
(Fig. 3 C). Similarly, the amount of biotin-BSA-Alexa647 going
to the wrong GFP pattern is only 0.9 ± 0.1% (n = 7) of the
amount going to its intended micropattern (Fig. 3 C). In addi-
tion, micropattern homogeneity was similar for both proteins
(Fig. 3 D), suggesting that both proteins were micropatterned at
a consistent density. We found that multiplexed micro-
patterning was very reproducible with this protocol and found
that the major source of variability between samples rather
came from occasional accidental drying of the coverslip during
the micropatterning process (Fig. S4, A and B).
As mentioned above, it is not enough that a protein micro-
patterns well; its activity must also be maintained on the micro-
pattern. Loss of activity during micropatterning can have multiple
origins: the micropatterning process itself can be detrimental to
proteins due to ROS generation and buffer composition when doing
LIMAP, but also, more generally, since micropatterning is an
adsorption-based process, proteins will micropattern with their
“stickier” side facing the glass, which could be the face harboring the
active site, therefore affecting activity or inducing unfolding. Fi-
brinogen anchors alleviate the buffer/ROS issue, but they potentially
could also improve orientation and conformational freedom, as the
protein of interest is not itself micropatterned but rather attached to
the micropattern via a flexible linker.
We thought to test this hypothesis using a commonly used assay
relying on adsorbed proteins, namely the microtubule (MT) gliding
assay (Fig. 4; Bachand et al., 2014). In this assay, kinesin molecular
motors are adsorbed onto glass, andmotorswith theirmotor domain
facing away from the glass can then move MTs around. While a
biotinylated fragment comprising the motor domain and the
dimerizing coiled-coil of Drosophila kinesin 1 (noted Kin1-
biotin; Subramanian and Gelles, 2007) is efficiently micro-
patterned onto PLL-PEG substrates (Fig. 4, A–D), its activity is
dramatically reduced when doing so: MTs move slowly (Fig. 4,
C and J, for quantification; and see also Video 1) and frequently
pause during their motion (Fig. 4, C and K, for quantification).
Conversely, micropatterning the same Kin1-biotin through a
“sandwich” on top of fibrinogen-biotin-ATTO490LS and Neu-
trAvidin (Fig. 4, E–H), restored expected gliding speeds (Fig. 4,
G and J, for quantification) with very rare pauses (Fig. 4, G and
K, for quantification; and see also Video 1). Importantly, in all
these experiments, we only detected motion in the micro-
patterned regions (Fig. 4 I), suggesting that MTs bound to the
surface outside the micropattern were not bound by kinesin
but rather by nonspecific interactions with the surface. This
demonstrates that fibrinogen anchors are a reliable way to
ensure high activity of micropatterned proteins, most likely by
ensuring a high density of correctly orientated proteins and by
mitigating surface-induced denaturation of the micropatterned
proteins of interest.
We then decided to apply our fibrinogen technology to fa-
cilitate applications that would otherwise be hard with existing
micropatterning techniques. Insect cells like Drosophila S2 cells
require lectins such as Con A to adhere on glass (Rogers et al.,
2002). However, Con A, in our hands, does not micropatternwell
(Fig. 5 A, compare “pattern” channel with fibrinogen for the
small micropatterns on the right side of each image), thereby
limiting the possibility of adhering these cells to small micro-
patterns, and therefore to micropattern single S2 cells. Note that
this is mainly a problem for small micropatterns, as cells manage
to adhere partially to large micropatterns (Fig. 5 A, left side of all
images). We thus derived fibrinogen–Con A (Fig. S2 A), which
dramatically improves micropatterning efficiency of S2 cells,
even onto small, single-cell micropatterns (Fig. 5 A, compare
“merge” channel between Con A and fibrinogen–Con A; see also
Fig. 5, B and C, for quantification of the cell density and speci-
ficity on the small micropatterns). The improvement in adhesion
was even clearer with medium-sized micropatterns, to which
several cells adhered per micropattern (Fig. S4 C).
We then thought to combine all the advantages of our tech-
nology to open a new avenue in micropatterning by achieving
subcellular micropatterning, whereby the position of proteins
within cells can be imprinted from the outside via a micropattern.
To achieve this, we made dual micropatterns with one micro-
pattern to anchor the cell and a secondmicropattern to relocalize a
transmembrane receptor via an active ligand presented in the
right orientation (Fig. 6 A; and Fig. 7, A and D). Obviously,
achieving this quantitatively relies on the ability to achieve
multiplexed micropatterning of proteins while maintaining their
activity and proper orientation. As a proof of concept, we used
NIH/3T3 cells stably expressing a model receptor composed of a
transmembrane segment fused to an extracellular GBP and
an intracellular mScarlet (GBP-TM-mScarlet), and dual micro-
patterns composed of a fibrinogen/fibronectin anchoring micro-
pattern, and a fibrinogen-biotin-ATTO490LS::streptavidin-GFP-
GFP relocalizing micropattern. Streptavidin-GFP-GFP refers to a
fusion between streptavidin and two copies of GFP. Importantly,
this setup achieved specific and quantitative relocalization of the
GBP-TM-mScarlet construct onto the GFP micropattern (Fig. 6, B
and C). Protein relocalization happened in a matter of minutes
when cells entered in contact with the GFP-positive part of the
micropattern during spreading and was then stable over time
(Fig. 6, D and E; and Video 2). Importantly, this result showcases
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the advantages of the highmicropatterning densities andmodularity
that are achievable with our fibrinogen toolbox, as micropatterns
offering lower GFP densities, such as direct micropatterning of GFP
or fibrinogen-GFP with a low degree of labeling, did not induce
noticeable GBP-TM-mScarlet relocalization (Fig. S5, A and B).
We then generalized this concept to endogenous receptor/ligand
pairs to establish controlled signaling platforms at the surface of
cells. First, a micropattern of a soluble ligand, namely EGF, proved
efficient at relocalizing its cognate receptor (EGFR) when anchored
via a fibrinogen-biotin::NeutrAvidin sandwich (Fig. 7, A and B; see
also Fig. 7 C for quantification). This was not observed without the
addition of biotinylated EGF (Fig. 7, B and C). Importantly, the poor
directmicropatterning of fluorescent EGF (Fig. S5 C)made this dual-
patterning assay impossible without fibrinogen anchoring. The
modular nature of the fibrinogen-anchoring technology also means
that even higher densities of active EGF could presumably be ach-
ieved using a ligand amplification strategy, akin to that used to
increase GBP-TM-mScarlet relocalization (Fig. 6, A and B). In-
terestingly, with EGFR relocalization, we found that clathrin
was also relocalized to the EGF::EGFRmicropattern (Fig. 7 B; see
Figure 3. Fibrinogen anchors facilitate multiplexed micropatterning of proteins. (A) Scheme illustrating the different steps for multiplexed micro-
patterning using fibrinogen anchors. Note that the two proteins to be micropatterned (GFP and BSA-biotin-Alexa647) are added together after the micro-
patterning process. This could help maintain protein activity, as proteins can be added in their optimal buffer (rather than the optimal micropatterning buffer)
and are not exposed to UV-induced ROS or the BBTB. (B) Bottom line: Multiplexed micropatterning of GFP and BSA-biotin-Alexa647 (5 µg/ml) with fibrinogen-
GBP and fibrinogen-NeutrAvidin anchors (50 µg/ml) using the scheme depicted in A onto PLL-PEG–coated glass. Top and middle lines: Controls of bottom
panel by exchanging fibrinogen-GBP with fibrinogen-Alexa546 (top line) or by exchanging fibrinogen-NeutrAvidin with fibrinogen-Alexa546 (middle line)
followed by coinjection of GFP and BSA-biotin-Alexa647. Note that there is high specificity of the proteins of interest for their respective anchor and minimum
overlap between the two proteins. This implies that the successive micropatterns of fibrinogen anchors have been efficiently quenched (otherwise the proteins
of interest could bind to the wrong micropattern). (C) Quantification of the increased specificity of GFP and BSA-biotin-Alexa647 for their respective
fibrinogen-GBP or fibrinogen-NeutrAvidin anchor, expressed as the amount protein going to the wrong patterns as a fraction of the amount going to the right
pattern (mean ± SEM). Statistics were performed using an unpaired t test. (D) Similarity of the micropatterning homogeneity of GFP on fibrinogen-GBP
micropatterns and BSA-biotin-Alexa647 on fibrinogen-NeutrAvidin micropatterns (mean ± SEM). n, number of micropatterns measured. Scale bar, 10 µm.
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also Fig. 7 C for quantification), suggesting that the EGF mi-
cropattern traps EGFR in an intermediate state along the en-
docytic pathway, as expected if the micropattern activates the
physiological signaling cascade downstream of EGFR activation
but prevents EGFR endocytosis because of the strong link to the
micropattern. Similarly, a micropattern of a ligand normally
exposed at the surface of cells, Delta, proved efficient at re-
localizing its cognate receptor, GFP-Notch, in live cells (Fig. 7,
D–F). As before with the synthetic GFP::GBP interaction, re-
localization of GFP-Notch by micropatterned Delta occurred in
the time scale of minutes as cells spread onto the micropattern
and remained stable over time (Fig. S5, D and E; and Video 3).
Discussion
The technology developed in this paper allows the micropatterning
of virtually any protein of interest with high selectivity and homo-
geneity.We envision that this will open new avenues for cell biology
applications, for instance, tomicropattern cell types that could not be
well micropatterned due to the low micropatterning efficiency of
their extracellular matrix of choice. In particular, the enhanced
micropatterning of Drosophila cells that we achieved in this work
(Fig. 5) opens a new avenue for cell biology, as it will allow us,
through the isolation of primary Drosophila cells, to combine quan-
titative, geometrically defined cell culture with the genetic tracta-
bility of Drosophila. Importantly, while we focused here on UV
micropatterning in a microscope (Strale et al., 2016), our technology
is general and applies to any light-induced micropatterning tech-
nique, such as Deep UV-Quartz-mask–based techniques (Fig. 5;
Azioune et al., 2009). The ability to functionalize fibrinogen with
nanobodies could also be a benefit for the clustering of receptors
against which antibodies have been developed due to the elegant
work by Pleiner et al. (2018), who recently released an extensive
toolkit of nanobodies targeting nearly all commonly used primary
antibodies. Indeed, these nanobodies are compatible with their ra-
tional cysteine-based nanobody engineering protocol (Pleiner et al.,
Figure 4. Fibrinogen anchors facilitate micro-
patterning of active motors. (A–H) Biotinylated-
Kinesin1 motors (Kin1-Biotin) were micro-
patterned on PLL-PEG–coated glass using LIMAP
either directly (A–D) or indirectly through a fi-
brinogen-biotin-ATTO490LS::NeutrAvidin sand-
wich (E–H; see Materials and methods). After
washing and quenching, GMPCPP-stabilized
fluorescent microtubules (MTs) were added
in the presence of ATP and their motion ob-
served by TIRFM. Dashed purple lines delin-
eate the kinesin micropattern as imaged either
through post-labeling of Kin1-Biotin by streptavidin-
Alexa647 for direct micropatterning (A–D) or by fi-
brinogen-biotin-ATTO490LS fluorescence for the
indirect micropatterning (E–H). (I) Quantification of
the proportion of motile MTs in all conditions re-
veals that MTs outside the micropattern are im-
mobile, in contrast to MTs landing inside the
micropattern (n = 14/34/47/112, respectively). (J
and K) Quantification of the speed (J; mean ± SEM)
and fraction of time spent moving processively (K;
mean ± SEM) reveals that MTs move faster and
with fewer pauses on fibrinogen-biotin–mediated
Kin1-Biotin micropatterns (directly micropatterned,
n = 7; sandwich, n = 25). This suggests that indirect
micropatterning of Kin1-Biotin through fibrinogen-
biotin ensures high activity of the motor on the
micropattern. Statistics in J and K were performed
using unpaired t tests. n, number of MTs. Scale
bars, 10 µm (B, D, F, and H) and 10 µm/1 min (C
and G). t, time.
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2015), which we rely on for fibrinogen functionalization with GBP.
Importantly,whilewe focused here on a fewcommonly used protein
tags, there is no reasonwhy other binders/ligands could not be fused
to fibrinogen, such as benzylguanine (to bind to SNAP-tagged pro-
teins), Strep-Tactin (to bind to Strep-Tag–tagged proteins; Schmidt
and Skerra, 2007), amylose (to bind to maltose-binding protein–
tagged proteins), or Spycatcher/Snoopcatcher (to bind to SpyTag/
SnoopTag-tagged proteins; Veggiani et al., 2016).
An additional major advantage of our method is that it en-
sures that micropatterned proteins maintain their activity,
which was best exemplified by our successful micropatterning
of active molecular motors (Fig. 4). This is especially important
for sequential micropatterning using LIMAP, as the ROS gen-
erated by UV light to micropattern the second protein can po-
tentially be harmful to the first micropatterned protein. This
improvement in activity is achieved by first micropatterning
fibrinogen anchors that specifically bind to purification tags,
followed by addition of the tagged proteins of interest. As the
proteins of interest are added after the actual micropatterning
process, they can be added in the optimal buffer for their sta-
bility/activity. Conversely, the fibrinogen anchor is micro-
patterned in its optimal buffer for micropatterning efficiency,
thereby removing the need to compromise between the two. It
must be emphasized that our technology also maximizes activity
by mitigating preferential orientation effects, as it ensures
that binding to the micropattern occurs at the level of the
protein tag, usually added to flexible N- or C-terminal regions,
rather than on the “stickiest” face of the protein, which could
also happen to be where the protein active site is. In partic-
ular, this allowed us to micropattern molecular motors spe-
cifically via their C-terminal tail away from their N-terminal
motor domain, thereby maintaining their activity (Fig. 4). We
envision that these key assets will provide major advantages for
in vivo studies, to micropattern active ligands in the right ori-
entation to bind to membrane receptors, but also for in vitro
studies, for multiplexed micropatterning of various molecular
motors to pave the way toward the in vitro reconstitution of
complex cytoskeleton landscapes, akin to those found in cells.
Figure 5. Fibrinogen anchors facilitates the micropatterning of hard-to-pattern cells. (A) Fibrinogen (doped with 10% fibrinogen-Alexa546), Con A
(doped with 10% rhodamine–Con A), or fibrinogen–Con A (doped with 10% fibrinogen-Alexa546) were micropatterned at 50 µg/ml onto PLL-PEG–coated glass
using deep-UV and a chromium mask. Coverslips were washed, and S2 cells were added for 1 h before addition of SiR-tubulin to label cells for 30 min. After
washing, cells and micropatterns were imaged by spinning-disc confocal microscopy. While S2 cells do manage to adhere to larger Con A micropatterns,
micropatterning efficiency of Con A is lower than that of fibrinogen (compare left panels), and therefore fibrinogen–Con A enables micropatterning of S2 cells
onto small, single-cell micropatterns. Note that fluorescence in the “pattern” channel cannot be directly compared as Con A and fibrinogen are not func-
tionalized with the same fluorophores. (B and C) Quantification of the effects seen in A (mean ± SEM; fibrinogen, n = 16; Con A, n = 14; fibrinogen–Con A, n =
11). Normalized micropatterned cell density (B) is significantly higher on small fibrinogen–Con A micropatterns compared with Con A or fibrinogen micro-
patterns, while the normalized nonspecific adhesion (C) is higher for fibrinogen and Con A than fibrinogen–Con A (see Materials and methods for details).
Statistics in B were performed using a one-way ANOVA test followed by a Tukey post hoc test (P < 0.001), while statistics in C were performed using a
Kruskal–Wallis test. n, number of fields of view analyzed. Scale bar, 100 µm. n.s., not significant.
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In addition to ensuring protein activity, our method also
minimizes cross-adsorption between successive micropatterns
as it simplifies micropattern quenching. In other words, not only
are the proteins active, but they are also at the right place (Fig. 1,
Fig. 3, and Fig. S1). Indeed, because it is always virtually the
same protein that is micropatterned, this simplifies the deter-
mination of the quenching conditions for each specific experiment.
Coupled to the constant homogeneity between micropatterns
brought by ourmethod, we envision that this propertywill be a key
advantage for multiprotein applications where control over the
relative micropatterning density between proteins is important, for
example, in testing the cellular response to multiple gradients of
signaling molecules.
While not a concern for in vitro experiments, fibrinogen
might not always be the anchor of choice when working with
cells, as it is itself a bioactive molecule. First, obviously,
Figure 6. Fibrinogen anchors enables the subcellular micropatterning of a synthetic receptor fused to a cortical protein of interest. (A) Experimental
scheme: NIH/3T3 cells stably expressing GBP-TM-mScarlet were allowed to spread on dual micropatterns of fibronectin/fibrinogen-Alexa647 and fibrinogen-
biotin-ATTO490LS::streptavidin-GFP-GFP, and were then imaged live by TIRF microscopy. (B) Efficient relocalization of the GBP-TM-mScarlet construct onto
an area defined by the extracellular GFP micropattern in live cells. (C) Quantification of the effects seen in B (mean ± SEM). Statistics were performed using a
Student’s t test. n, number of cells analyzed. (D) Cells as in B were imaged by TIRF microscopy during spreading to evaluate the kinetics of GBP-TM-mScarlet
recruitment onto the GFP micropattern. Fibrinogen and GFP micropatterns are outlined in blue and green dashed lines, respectively. (E) quantification of the
effects seen in D (mean ± SEM; number of cells analyzed: 11 for control and 32 for Streptavidin-GFP-GFP). Scale bar, 10 µm. Ctrl, control; Strept., streptavidin.
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Figure 7. Fibrinogen anchors enables the subcellular micropatterning of endogenous receptors. (A) Experimental scheme. Serum-starved HeLa cells
were allowed to spread on dual micropatterns of fibronectin/fibrinogen-Alexa546 and fibrinogen-biotin-ATTO490LS::NeutrAvidin/biotin-EGF, then fixed and
Watson et al. Journal of Cell Biology 11 of 21
Fibrinogen-enhanced micropatterning https://doi.org/10.1083/jcb.202009063
fibrinogen anchors are probably not suited to study cell types
involved in the biology of fibrinogen, like platelets. Indeed, any
secreted thrombin activity would likely render the anchors
nonfunctional. Furthermore, while some cells do not bind to
fibrinogen, such as S2 cells (Fig. 5), fibrinogen has been widely
used to functionalize surfaces to allow cell adhesion. If cells just
bind to fibrinogen as they would bind to extracellular matrix
proteins (like fibronectin), then using fibrinogen as an anchor to
micropattern ligands asymmetrically, like we do in Fig. 6 and
Fig. 7, would actually be an advantage, as the density of adhesion
sites could be kept identical between the fibrinogen and
fibrinogen-ligand part of the micropatterns. However, if one
wants to investigate cell mechanics by functionalizing fibrino-
gen with force sensors (LaCroix et al., 2018; Blakely et al., 2014)
or light-controlled force inducers (Zheng et al., 2020 Preprint),
then the direct binding of the cell to the fibrinogen itself rather
than the force-sensing/inducing moiety would be an issue, as it
will interfere with the experiments. Another potential concern
for these experiments is that if cells are able to bind to fibrin-
ogen (or fibrinogen anchors), then strong enough cells might be
able to rip off the micropatterns over time, as was shown pre-
viously with fibronectin (Fink et al., 2007). Indeed, as good as
fibrinogen micropatterns are, they are still achieved by protein
adsorption. While we did not observe this in any of the ex-
periments described in this paper, as all fibrinogen micro-
patterns presented in this study were stable when interacting
with 3T3, HeLa, and U2OS cells (Fig. 6 and Fig. 7), this might be a
concern for researchers working with other cells and/or much
longer experiments. A solution to this potential problem could
be to use mild aldehyde or N-hydroxysuccinimide (NHS) fix-
atives to cross-link the fibrinogen molecules of the micropattern
before adding cells. Indeed, fibrinogen functionalized in the
conditions described here still offers reactive amines, a property
we exploited to generate bi-functional fibrinogens like fibrino-
gen-biotin-ATTO490LS. Conversely, one could also tune the in-
teraction between the anchor and the cell, using weaker
nanobodies for instance, so the anchor would unbind when the
cell pulls too much on it. These potential caveats notwithstanding,
now that we have identified the key properties that make a good
micropatterning anchor, it would be an interesting avenue of
future research to find an alternative to fibrinogen that has no
biological activity.
The combination of all the advantages offered by our tech-
nology enabled us to achieve subcellular micropatterning of
proteins, whereby the position of proteins can be imprinted
from the outside via a micropattern (Fig. 6 and Fig. 7). This was
not possible with direct micropatterning of ligands (Fig. S5, B
and C), demonstrating the importance of the fibrinogen toolbox
described here. While beyond the scope of this paper, we envi-
sion that this technology will allow researchers to untangle the
interplay between mechanical forces (provided by the distri-
bution of adhesion molecules) and signaling (provided by the
distribution of signaling receptors). Conversely, by trapping
endogenous receptor-ligand complexes into the total internal
reflection fluorescence (TIRF) field while blocking their endo-
cytosis, this assay could help the characterization of the se-
quence of recruitment of proteins at endocytic sites, which could
be then structurally characterized thanks to the recent combi-
nation of CryoEM and micropatterning (Toro-Nahuelpan et al.,
2020; Engel et al., 2019). Furthermore, the reconstitution of
signaling platforms of defined receptor-ligand content at a
known density is poised to help decipher the combinatorial
interactions between signaling pathways, such as the cross-
talk between EGFR and Her2, which has been proposed to
underlie resistance to anticancer drugs targeting these re-
ceptors (Yamaguchi et al., 2014). Last, the orthogonal trans-
membrane segment we established (Fig. 6) could be used to
relocalize other, intracellular proteins to the cell cortex in a con-
trollable fashion via a micropattern, an assay reminiscent of what
we previously achieved in vivo using polarity markers as an an-
choring platform (Derivery et al., 2015). This could, for instance,
be used to generate symmetry breaking of the actin cortex via
asymmetric targeting of cytoskeleton regulators (by fusing cyto-
skeleton regulators to the transmembrane construct, for instance).
In conclusion, we hope that the advantages of the fibrinogen
anchors described in this paper will be a stepping-stone toward
having micropatterning experiments limited only by the imag-
ination of the researcher rather than by intrinsic limitations of
this powerful technology.
Materials and methods
Synthesis of the photosensitizer BBTB
All chemical reagents were purchased with the highest purity
available. Briefly, in a 100-ml round-bottom flask, 2.1 ml tri-
methylamine solution 4.2 M in ethanol (1.2 equivalents, 8.8
mmol; Sigma-Aldrich) was added to 2.0 g of 4-(bromomethyl)
benzophenone (1 equivalent, 7.3 mmol; Sigma-Aldrich) re-
suspended in 40 ml acetonitrile. The reaction was placed under
reflux for 2 h in a nitrogen atmosphere. Once the reaction was
completed, the solvent was evaporated, and the white solid ob-
tained was dried under vacuum (2.35 g, 97% yield).
Characterization of the product: high-performance liquid
chromatography (HPLC): 95% pure; 1H nuclear magnetic reso-
nance (400 MHz, deuterated methanol) δ: 7.93 (m, 2H), 7.84 (m,
2H), 7.77 (m, 2H), 7.70 (m, 1H), 7.58 (m, 2H), 4.71 (s, 2H), 3.22 (s,
9H). 13C nuclear magnetic resonance (400 MHz, deuterated
methanol) δ: 139.5, 136.8, 132.8, 132.8, 131.7, 130.0, 129.7, 128.3,
68.3, 52.0; mass spectrometry (electrospray ionization) [m-Br]+/
z calculated for C17H20NO: 254.1, found: 254.1.
processed for immunofluorescence against EGFR and clathrin. (B) Efficient relocalization of the EGFR onto the active EGF micropattern. Note that clathrin is
also recruited onto the micropattern. (C) Quantification of the effects seen in D (mean ± SEM). (D) Experimental scheme. U2OS cells stably expressing GFP-
Notch1 were allowed to spread on dual micropatterns of fibronectin/fibrinogen-Alexa647 and fibrinogen-biotin-ATTO490LS::NeutrAvidin::biotin-DLL4 and
imaged live 20 min later. (E) Efficient relocalization of GFP-Notch1 onto the active DLL4 micropattern. (F) Quantification of the effects seen in E (mean ± SEM).
All statistics in this figure were performed using Student’s t tests. n, number of cells analyzed. Scale bar, 10 µm. Ctrl, control.
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Plasmids
The GBP3xCys consists of a nanobody against GFP (Rothbauer et
al., 2008), referred to as GBP, with three cysteines added far
from the active site to minimize loss of activity upon function-
alization through these cysteines (Pleiner et al., 2015). GBP3xCys
was amplified by PCR from the P434_H14-Sp-brNEDD8-Cys-
anti-GFP nanobody (a kind gift from Tino Pleiner, Max Planck
Institute for Biophysical Chemistry, Göttingen, Germany) and
cloned into a modified pRSET vector (a kind gift from Mark
Allen, Medical Research Council Laboratory of Molecular Biol-
ogy, Cambridge, UK) tagging N-terminally the ORF with a (His)6
tag, followed by the first 93 amino acids of the dihydrolipoyl
acetyltransferase component of pyruvate dehydrogenase com-
plex from Bacillus stearothermophilus to enhance solubility (as
previously described by Watson et al., 2020), and a tobacco etch
virus (TEV) cleavage site (referred to as His-SS-TEV). Primers
used to amplify GBP3xCys were Fse_gbp_3cys: 59-ATGCGGCCG
GCCCTGCGGATCCCAGGTACAGCT-39 and Asc_gbp_3cys: 59-
ATGCGGCGCGCCCTTAACACCTAGTACCGGAGCTGC-39. EGFP
was PCR-amplified from pEGFP-C2 (Clontech) and similarly
cloned into the pRSET His-SS-TEV vector using the following
primers: Fse_GFP_pRSET: 59-ATGCGGCCGGCCCATGAGCAA
GGGCGAGGAGCTGTT-39 and Asc_GFP_pRSET: 59-ATGCGG
CGCGCCCTTACTTGTACAGCTCGTCCATGC-39.
pWC2 (Subramanian and Gelles, 2007) encoding the motor
domain of Drosophila kinesin 1 fused to the biotin carboxyl car-
rier protein noted Kin1-biotin was a gift from Jeff Gelles (De-
partment of Biochemistry, Brandeis University, Waltham, MA;
Addgene plasmid no. 15960; http://n2t.net/addgene:15960; Re-
search Resource Identifier: Addgene_15960).
For the purification of streptavidin-GFP-GFP, two GFPs were
cloned into the pRSET His-SS-TEV-streptavidin vector, which
permits solubilization of natively purified streptavidin (Watson
et al., 2020). The GFP sequences were codon optimized to pre-
vent repetitive sequences. The resulting template was synthe-
sized by GeneArt (Thermo Fisher Scientific) and PCR-amplified
using the following primers: Fse_2XGFP_f: 59-ATGCGGCCGGCC
CATGGTGAGCAAGGGCGAGGA-39 and Asc_2XGFP_r: 59-ATG
CGGCGCGCCCCTAATGATGATGATGATGATGTTTATACAATT
CATCCATAC-39.
The transmembrane nanobody construct (Fig. 6) com-
prises an N-terminal signal peptide from the Drosophila
echinoid protein, followed by (His)6–Protein C tandem af-
finity tags, the GBP nanobody against GFP (Rothbauer et al.,
2008), a TEV protease cleavage site, the transmembrane
domain from the Drosophila echinoid protein, the vesicular
stomatitis virus G export sequence, and the mScarlet protein
(Bindels et al., 2017). The protein expressed by this construct
thus consists of an extracellular anti-GFP nanobody linked to
an intracellular mScarlet by a transmembrane domain
(named GBP-TM-mScarlet in the main text for simplicity).
This custom construct was synthesized by IDT and cloned
into a modified pCDNA5/FRT/V5-His vector (Thermo Fisher
Scientific), where the cytomegalovirus promoter was re-
placed by the EF1α/human T-lymphotropic virus chimera
promoter from the pFUSE fragment crystallizable region
vector (pFUSE Fc; Invivogen). This modification did not
affect the ability of the plasmid to undergo homologous re-
combination into the FRT site (FlipIn system; Thermo Fisher
Scientific). The C-terminal V5-His tandem tag present in the
plasmid is not translated because of a stop codon introduced
at the end of the mScarlet sequence in the synthesized GBP-
TM-mScarlet sequence.
Proteins
Unless stated otherwise, all protein purification steps were
performed at 4°C. Protein concentration was determined either
by absorbance at 280 nm or by densitometry on a Coomassie-
stained SDS page gel against a BSA ladder.
GBP3xCys, streptavidin-GFP-GFP, and GFPwere expressed in
Escherichia coli BL21 Rosetta 2 (Stratagene) using the plasmids
described above by induction at OD 600 = 0.8 with 1 mM IPTG in
2× yeast triptone (streptavidin-GFP-GFP) or terrific broth (GFP,
GBP3xCys) mediua at 20°C. Bacteria were lysed by sonication in
lysis buffer (20 mM Hepes, 150 mM KCl, 1% Triton X-100, 5%
glycerol, 20 mM imidazole, 5 mM MgCl2, and 0.5 mM DTT, pH
7.6) enriched with protease inhibitors (RocheMini) and 1 mg/ml
lysozyme (Sigma-Aldrich) and 10 µg/ml DNase I (Roche). After
clarification (16,000 rpm, Beckman JA 25.5, 30 min, 4°C), lysate
was incubated with nickel-chelating nitrilotriacetic acid (Ni-
NTA) resin (Qiagen) for 2 h at 4°C and washed extensively in
20 mM Hepes, 150 mM KCl, 5% glycerol, 15 mM imidazole, and
0.5 mM DTT, pH 7.6. Protein was eluted in 20 mM Hepes,
150 mM KCl, 5% glycerol, 250 mM imidazole, and 0.5 mM DTT,
pH 7.6. Bradford-positive elution fractions were pooled and
TEV-cleaved overnight by adding 1:50 (vol:vol) of 2 mg/ml (His)
6-TEV protease and 1 mM/0.5 mM final DTT/EDTA. The solution
was then dialyzed twice against 20 mM Hepes, 150 mM KCl,
15 mM imidazole, and 0.5 mM DTT, pH 7.7, and TEV protease
and His-SS-TEV were removed using Ni-NTA resin. Tag-free
GBP3xCys was then concentrated down to 10 mg/ml, flash fro-
zen in liquid N2, and kept at −80°C. GFP and streptavidin-GFP-
GFP were similarly purified, except that DTT was omitted in the
lysis and storage buffers, and that the final concentration was
4.22 mg/ml (GFP) and 0.75 mg/ml (streptavidin-GFP-GFP).
BSA-LC-LC-biotin-Alexa647 (BSA-biotin-Alexa647) was
generated by reacting 30 µM BSA (BP1605; Thermo Fisher
Scientific; dissolved in 0.1 M sodium bicarbonate, pH 8.3) si-
multaneously with a fivefold molar excess of Alexa647 NHS
ester (A20006; Thermo Fisher Scientific) and a fivefold molar
excess of EZ-Link NHS LC-LC-biotin (21343; Thermo Fisher
Scientific). Both NHS-reactive chemicals were resuspended
immediately before the reaction in a new vial of anhydrous
DMSO (D12345; Invitrogen). The reaction was rocked for 1 h at
RT before removal of unreacted Alexa647 and biotin on a Zeba
Spin column (89891; Thermo Fisher Scientific) equilibrated in
0.1 M sodium bicarbonate, pH 8.3. The degree of Alexa647
labeling was 1.48 mol of dye per mol of BSA, and the resulting
BSA-biotin-Alexa647 visually bound to agarose beads conju-
gated to streptavidin (20359; Pierce).
To generate streptavidin-Alexa647, streptavidin (1 mg/ml in
PBS plus 60mM sodium bicarbonate, pH 8.0) was reacted with a
sixfold molar excess of Alexa647 NHS ester (A20006; Thermo
Fisher Scientific). Excess dye was removed by Zeba Spin column
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equilibrated in 20 mM Hepes, 150 mM KCl, and 5% glycerol,
pH 7.6.
Kin1-biotin was expressed using the plasmid pWC2 by induction
at OD 600 = 0.8 with 1 mM IPTG in 2× yeast triptone medium at
20°C. Bacteria were lysed by sonication in lysis buffer (20 mM
Hepes, 150 mM KCl, 1% Triton X-100, 5% glycerol, 0.1 mM ATP,
10 mM imidazole, 10 mM MgCl2, and 1 mM DTT, pH 7.6) enriched
with protease inhibitors (Roche Mini) and 0.7 mg/ml lysozyme
(Sigma-Aldrich) and 10 µg/ml DNase I (Roche). After clarification
(14,000 rpm, 30 min, 4°C; Beckman JA 25.5), lysate was incubated
withNi-NTA resin (Qiagen) for 2 h at 4°C andwashed extensively in
wash buffer (20 mMHepes, 150 mMKCl, 5% glycerol, 0.1 mMATP,
10mM imidazole, 2mMMgCl2, and 1mMDTT, pH 7.6), followed by
wash buffer enriched with 2 mM ATP and a final wash in wash
buffer. Protein was eluted in 20 mM Hepes, 150 mM KCl, 5% glyc-
erol, 0.1 mMATP, 300mM imidazole, 2 mMMgCl2, and 1 mMDTT,
pH 7.6. Bradford-positive elution fractionswere pooled and diluted 1:
11 (vol eluate:vol QA) in buffer QA (20mMHepes, 20mMKCl, 1mM
MgCl2, 0.05mMATP, and 1mMDTT, pH 7.6) before loading onto an
MonoQ 5/50 GL anion exchange column (0.5 ml/min). Protein was
then eluted in a 0.05–1 M gradient of KCl. Positive fractions were
pooled, dialyzed against storage buffer (20 mM Hepes, pH 7.7,
150mMKCl, 1 mMMgCl2, 0.05 mMATP, 1 mMDTT, and 20% (wt/
vol) sucrose, pH 7.6), flash frozen in liquid N2, and kept at −80°C
(final concentration, 2.2 mg/ml).
NeutrAvidin, NeutrAvidin DyLight-550, and Fibrinogen-
Alexa546 were purchased from Thermo Fisher Scientific. Unla-
beled fibrinogen was purchased from MP Biomedicals (08820224).
Tubulin, HiLyte-647 tubulin, and biotinylated tubulin were
all purchased from Cytoskeleton. GMPCPP-stabilized MTs were
polymerized by resuspending 1-µl aliquots of HiLyte-647–labeled
tubulin mixes (60% unlabeled tubulin, 20% HiLyte-647 tubulin,
20% biotinylated tubulin; T240, TL670M, and T333, respectively;
Cytoskeleton, Inc.) in 50 µl of warm solution (80 mM Pipes,
2 mM MgCl2, 0.5 mM EGTA, and 0.6 mM GMPCPP, pH 6.9),
before incubation for 30 min at 37°C. MTs were pelleted for
8 min at 15,871 g and resuspended in 50 µl of 80mMPipes, 2 mM
MgCl2, 0.5 mM EGTA, and 0.6 mM GMPCPP, pH 6.9.
Delta-like ligand 4 (DLL4), comprising a fragment of the human
Delta ectodomain (1–405) with a C-terminal GS-SpyTag-His6 se-
quence,was purified from culturemediumof transiently transfected
Expi293F cells (Thermo Fisher Scientific) by metal affinity chro-
matography. Protein was further purified by size exclusion chro-
matography on a Superdex 200 column in 50 mM Tris, pH 8.0,
150 mM NaCl, and 5% glycerol. DLL4 (69 µM) was subsequently
buffer exchanged into 0.1 M sodium bicarbonate, pH 8.3, using a
Zeba Spin column and labeled with a threefold molar excess of EZ-
Link NHS LC-LC-biotin (Thermo Fisher Scientific) for 1 h at RT.
Unreacted biotin was then removed by Zeba Spin column equili-
brated in 0.1 M sodium bicarbonate, pH 8.3.
Fibrinogen fusions
Three-step synthesis of fibrinogen-NeutrAvidin, fibrinogen GFP, and
fibrinogen–Con A
Fibrinogen powder was resuspended at 4 mg/ml (∼11.8 µM) in
fibrinogen buffer (0.1 M sodium bicarbonate, 0.5 mM EDTA, pH
8.3) before addition of a 25-fold molar excess of Traut’s Reagent
(2-iminothiolane; Pierce). The solution was gently rocked for
45min at RT. 1 mMDTT final concentrationwas then added, and
the solutionwas further rocked for 1 h at RT. Excess DTT/Traut’s
reagent was then removed using a Zeba Spin column equili-
brated in fibrinogen buffer. Concomitantly, the buffer of puri-
fied NeutrAvidin (80 µM) was exchanged for fresh fibrinogen
buffer using a Zeba Spin column, and then a sixfoldmolar excess
of maleimide-PEG8-succinimidyl ester (746207; Sigma-Aldrich)
was added. After rocking for 1 h at RT, the excess maleimide-
PEG8-succinimidyl ester was removed on a Zeba Spin column
equilibrated in fibrinogen buffer. NeutrAvidin-maleimide was
then added to fibrinogen-thiol in a fourfold NeutrAvidin-mal-
eimide/fibrinogen molar ratio and rocked overnight at 4°C.
50 mM final free cysteine was then added and incubated
for 30 min at RT to quench the remaining unreacted maleimide
functions. The solution was then brought to 25% final am-
monium sulfate by adding one third of the volume of saturated
ammonium sulfate to specifically precipitate the fibrinogen-
NeutrAvidin. After 30 min rocking at RT, the solution was centri-
fuged at 16,873 g for 10 min. The pellet was resuspended in the
initial volume of fibrinogen buffer by gentle rocking for 1 h at 4°C,
followed by a second precipitation in 25% final ammonium sulfate
as above. After centrifugation at 16,873 g for 10 min, the pellet was
resuspended in one quarter of the initial volume of fibrinogen
buffer, ultracentrifuged to remove aggregates (100,000 g, 5 min at
4°C), then flash frozen in liquid N2 and kept at −80°C.
Fibrinogen-GFP was similarly obtained by replacing Neu-
trAvidin by purified GFP, and, in this case, we used a 15-fold
molar excess of GFP-maleimide over fibrinogen-thiol. The ab-
sorbance at 488 nm of GFP allowed us to evaluate the degree of
labeling to 0.51 mol of GFP per mol of fibrinogen in these
conditions.
Fibrinogen–Con A was similarly obtained by replacing Neu-
trAvidin with purified Con A (Sigma-Aldrich).
Two-step synthesis of fibrinogen-GBP
Fibrinogen powder was resuspended at 4 mg/ml (∼11.8 µM) in
fibrinogen buffer (0.1 M sodium bicarbonate and 0.5 mM EDTA,
pH 8.3), and then a 25-fold molar excess of maleimide-PEG8-
succinimidyl ester was added. After rocking for 1 h at RT, the
excess maleimide-PEG8-succinimidyl ester was removed on a
Zeba Spin column equilibrated in fibrinogen buffer. Concomi-
tantly, the buffer of purified GBP3xCys was exchanged for fresh
fibrinogen buffer using a Zeba Spin column, which also removed
the DTT used in the purification of the GBP3xCys to keep cys-
teines reduced. GBP3xCys (10 mg/ml) was then added to
fibrinogen-maleimide in a fivefold GBP::fibrinogen-maleimide
molar ratio and rocked overnight at 4°C. 50 mM (final) free
cysteine was then added and incubated for 30 min at RT to
quench the remaining unreacted maleimide functions. Then the
solution was brought to 25% final ammonium sulfate as above to
specifically precipitate the fibrinogen-GBP. After 30min rocking
at RT, the solutionwas centrifuged at 16,873 g for 10min, and the
pellet was resuspended in the initial volume of fibrinogen, fol-
lowed by a second precipitation in 25% final ammonium sulfate.
After centrifugation at 16,873 g for 10 min, the pellet was re-
suspended in one quarter of the initial volume of fibrinogen
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buffer, ultracentrifuged to remove aggregates (100,000 g, 5 min
at 4°C), then flash frozen in liquid N2 and kept at −80°C.
One-step synthesis of fibrinogen-biotin, fibrinogen-Alexa647,
fibrinogen-ATTO488, fibrinogen-biotin-ATTO490LS, and
fibrinogen-biotin-Alexa647
Fibrinogen-biotin was obtained by mixing fibrinogen (4 mg/ml
in fibrinogen buffer: 0.1 M sodium bicarbonate and 0.5 mM
EDTA, pH 8.3) with a 20-fold molar excess of EZ-Link NHS LC-
LC-biotin (Pierce) for 1 h at RT. Unreacted biotin was then re-
moved by dialysis against fibrinogen buffer (2 × 2 liters).
Fibrinogen-Alexa647 and fibrinogen-ATTO488 were ob-
tained by reacting fibrinogen (4 mg/ml in fibrinogen buffer)
with a 10-fold molar excess of NHS-Alexa647 (A20006; Thermo
Fisher Scientific) or NHS-ATTO 488 (ATTO-TECH AD 488–31),
respectively, for 1 h at RT. Unreacted dye was then removed by
Zeba Spin column equilibrated in fibrinogen buffer.
Fibrinogen-biotin-ATTO490LS and fibrinogen-biotin-Alexa647
were generated by mixing fibrinogen (4 mg/ml in fibrinogen
buffer) with a threefold molar excess of ATTO490LS NHS ester
(ATTO-TEC) or Alexa647 NHS ester (A20006; Thermo Fisher
Scientific) for 15 min at RT. The fibrinogen-ATTO490LS and
fibrinogen-Alexa647 were subsequently reacted with a 50-fold
molar excess of EZ-Link NHS LC-LC-biotin for 1 h at RT. Un-
reacted biotin and fluorescent dye were then removed by Zeba
Spin column equilibrated in fibrinogen buffer.
Cells
Drosophila S2 cells (mycoplasm-free judged by DAPI staining;
University of California, San Francisco) were grown in Schneider
Medium (Gibco) supplemented with 10% heat-inactivated FBS.
Flp-In NIH/3T3 cells (Invitrogen) were cultured in DMEM
(Gibco) supplemented with 10% Donor Bovine Serum (Gibco) and
Pen/Strep 100 units/ml at 37°C with 5% CO2. HeLa cells (CCL-2;
American Type Culture Collection) were cultured in DMEM
supplemented with 10% FBS (Gibco) and Pen/Strep 100 units/ml
at 37°C with 5% CO2. U2OS cells (HTB-96; ATCC) stably ex-
pressing inducible FLAG-Notch1-EGFP chimeric receptors
(Malecki et al., 2006) were maintained in DMEM supplemented
with 10% FBS, Pen/Strep 100 units/ml, 50 µg/ml hygromycin B
(Thermo Fisher Scientific), and 15 µg/ml blasticidin (Invitrogen)
at 37°C with 5% CO2. Prior to use in experiments, U2OS cells were
induced with 2 µg/ml doxycycline for 24 h. Flp-In NIH/3T3 were
transfected with a modified pCDNA5 vector containing GBP-TM-
mScarlet with lipofectamine 2000 (Invitrogen). Stable trans-
fectants by homologous recombination at the FRT site were ob-
tained according to the manufacturer’s instructions by selection
with 100 µg/ml Hygromycin B Gold (Invivogen). All live imaging
was performed in Leibovitz’s L-15 medium (11415064; GIBCO
BRL) supplemented with 10%Donor Bovine Serum andHepes (20
mM; 1563080; GIBCO BRL).
Immunofluorescence
Cells were fixed 4% paraformaldehyde in PBS for 20 min, per-
meabilized with 0.1% Triton X-100 in PBS for 5 min, then
washed in PBS, then in PBS supplemented with 1% BSA and 1%
rabbit IgG blocking reagent (Thermo Fisher Scientific) for 5 min,
then in PBS. Anti-clathrin (ab21679; Abcam) and anti-EGF re-
ceptor (D38B1; Cell Signaling) were labeled with Alexa488- and
Alexa647-Zenon rabbit IgG labeling kits, respectively (Thermo
Fisher Scientific), according to the manufacturer’s instructions,
and cells were then incubated with both antibodies (both diluted
1:100 in PBS–1% BSA) for 20 min. After washing thrice in PBS,
imaging was performed in PBS instead of mounting medium to
avoid squashing the cells (and potentially biasing the clathrin or
EGFR micropattern colocalization).
Microscopy
Imaging was performed on a custom TIRF/spinning-disk con-
focal microscope composed of a Nikon Ti stand equipped with
perfect focus and a 100× NA 1.45 Plan Apochromat lambda ob-
jective (or alternatively, a 60× NA 1.49 Apochromat TIRF or a 10×
NA 0.3 Plan Fluor). The confocal imaging arm is composed of a
Yokogawa CSU-X1 spinning-disk head and a Photometrics 95B
back-illuminated sCMOS camera operating in global shutter
mode and synchronized with the spinning-disk rotation. Con-
versely, the TIRF imaging arm is composed of an azimuthal TIRF
illuminator (iLas2; GATACA Systems) modified to have an ex-
tended field of view (Cairn) to match the full field of view of the
camera. Images are recorded with a Photometrics Prime 95B
back-illuminated sCMOS camera run in pseudo-global shutter
mode and synchronized with the azimuthal illumination. Exci-
tation is performed using 488- (150 mWOBIS LX), 561- (100mW
OBIS LS), and 637-nm (140mW OBIS LX) lasers fibered within a
Cairn laser launch. To minimize bleed-through, single-band
emission filters are used (Chroma 525/50 for GFP/ATTO488,
595/50 for Alexa546, and ET655lp for Alexa647/ATTO647N/
ATTO490LS/SiR-tubulin), and acquisition of each channel is
performed sequentially using a fast filter wheel (Cairn Optospin)
in each imaging arm. Filter wheels also contain a quad-band
filter (Chroma ZET405/488/561/640m) to allow imaging of the
reflection of the DMD illumination arm at the glass/water in-
terface (see below). To enable fast acquisition, the entire setup is
synchronized at the hardware level using an field-programmable
gate array (FPGA) stand-alone card (sbRIO 9637; National In-
strument) running custom code. TIRF angle was set indepen-
dently for all channels so that the depth of the TIRF field was
identical for all channels. Sample temperature wasmaintained at
25°C using a heating enclosure (https://MicroscopeHeaters.
com). Acquisition was controlled by Metamorph software.
Optical design of a low-cost UV light-emitting diode (LED)
DMD illuminator
Our optical design combines DMD-UV illumination with TIRF
illumination onto the Nikon Ti setup described above (Fig. S1 A).
Briefly, a 385-nm high-power UV LED light source (M385LP1;
Thorlabs) is collimated using an antireflective (AR)-coated
aspheric lens (ACL2520U-A; Thorlabs). The collimated UV beam
is then directed toward a DMD (DLPLCR6500EVM; Texas In-
struments) at a 24° angle of incidence (corresponding to twice
the tilting angle of the DMD mirrors). The image of the DMD
chip is then relayed onto the conjugate of the sample plane at
the backport of the microscope through a 4f imaging system (f1
= f2 = 125 mm UV Fused Silica Bi-Convex Lenses, AR-Coated,
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LB4913-UV; Thorlabs). This intermediate image is then relayed
onto the sample plane by a tube lens (125 mm, UV rated; Ed-
mond Optics) and the objective (100× Plan Apochromat lambda
NA 1.45, Plan Apochromat 60× NA 1.4, or 20× Plan Apochromat
Lambda VC NA 0.75). To combine DMD-UV illumination with
TIRF illumination, an ultraflat dichroic (T470lpxr; Chroma) is
placed after f2 within a custom backport assembly (Cairn).
When in DMD-UV illumination mode, the microscope filter
cube turret contains a 473-nm dichroic (Di03-R473; Semrock),
while it contains an ultraflat quad-band dichroic/clean-up filter
(TRF89901-EM; Chroma) when in TIRF illumination mode. The
473-nm dichroic is compatible with simultaneous spinning-
disk/DMD illumination. We note that care must be taken with
the adjustment of the collimating lens of the LEDs to find the
best compromise between illumination intensity and flatness of
the illumination profile. If necessary, a flatfield correction can
be applied on the micropatterns to be displayed to account for
any field inhomogeneities, and if extremely sharp micro-
patterns are required, an iris can be put in the Fourier plane
between f1 and f2, but we found that this was not required for
most applications.
To offer a second illumination wavelength for 450-nm op-
togenetic stimulation using the same DMD chip, our design also
contains a second collimated LED (450 nm; M450LP1; Thorlabs,
in our case) at the symmetric −24° angle. Therefore, any mi-
cropattern can be displayed using the 450-nm light source by
simply inverting the micropattern before displaying it on the
DMD. This could be replaced by any other light source to bring
epifluorescence imaging in order to facilitate multiprotein mi-
cropattern alignment on a setup not equipped with TIRF.
LED intensity is controlled using a custom LED driver pro-
viding the maximum 1.7 A tolerated by the LED (2 A for 450 nm
LED). Control over LED intensity and on/off state is operated
using a digital/analogue card (USB-6001; National Instrument;
or Arduino UNO equipped with a custom shield providing a
Texas Instrument TLV5618 digital/analogue chip). Communi-
cation to the DMD from the imaging software is performed using
the DMD Connect library developed by Hueck (2016), available
at https://github.com/deichrenner/DMDConnect. Control of all
parts was integrated into Metamorph and/or Micromanager
using custom scripts to calibrate the DMD with respect to the
camera, display user-defined UV micropatterns, and facilitate
micropattern alignment for multiprotein micropatterning.
To keep the cost low and to enable researchers with limited
access to mechanical workshops to make their own module, our
design relies on a commercially available cage system to set the
+24° angle and a custommount for the DMD board, which can be
machined or 3D printed. This greatly facilitates alignment of the
setup, as this essentially locks all pieces into the correct angle
during assembly, which is critical for alignment of DMD setups
(Strale et al., 2016). All codes and computer-aided design files for
this setup are available freely upon request for noncommercial
purposes.
Importantly, efficient and crisp micropatterning requires
that the microscope is focused on the PLL-PEG (or PEG-silane)/
glass interface. While hardware autofocus systems help in
finding this interface, they do not always work perfectly as there
is usually a correction offset to add, which may vary from
sample to sample. To ensure that we always focus the instru-
ment at the right place, we use the fact that because micro-
patterning is performed in aqueous buffer, there is a glass/liquid
interface at the PLL-PEG layer, which reflects the UV micro-
patterning light. We thus chose our filter/dichroic sets to allow
some of this reflected light to be imaged onto the camera, which
allows us to easily find the optimal sample plane in the absence
of anything fluorescent in the chamber. Once this plane has been
found, we activate the hardware autofocus system to ensure that
this plane is kept during micropatterning process.
Protein micropatterning
For micropatterning on PLL-PEG–passivated coverslips in an
open configuration (all micropatterns except Fig. S3), clean
room–grade coverslips (custom 25 × 75–mm size; Nexterion)
were surface activated under pure oxygen in a plasma cleaner
(PlasmaPrep2; GaLa Instruments) and then laid on top of a 200-
µl drop of filtered PLL(20)-g[3.5]-PEG(2) (PLL-PEG; 100 µg/ml
in 10 mM Hepes, pH 7.6; SuSoS) for 1 h in a humid chamber.
Coverslips were then washed extensively in filtered MilliQ
water and dried under a flow of dry nitrogen gas. Coverslips
were then mounted in a sticky slide Ibidi 8-well chamber
(80828; Ibidi) and pressed under a ∼4-kg weight overnight to
stick the chamber to the glass. Then, per well of the 8-well
chamber, 200 µl of BBTB was added (50 mM in 0.1 M sodium
bicarbonate, pH 8.3) and exposed to micropatterned UV light
using the DMD-UV arm of the micropatterning microscope
(30–90-s exposure) after focusing on the glass/buffer interface.
BBTB was subsequently removed by repeated dilution (12
washes with 600 µl of 0.1 M sodium bicarbonate, pH 8.3) before
addition of 200 µl of fibrinogen anchor (100 µg/ml in 0.1 M
sodium bicarbonate, pH 8.3, for a final concentration of 50 µg/
ml). The fibrinogen anchor was allowed to adsorb to the surface
for 5 min before washing by repeated dilution (12 washes). The
surface was then quenched for 5 min with 0.5 mg/ml PLL-PEG
(in 10mMHepes, pH 7.6). PLL-PEGwas then removed by similar
repeated dilution, so that the surface never dried. The protein of
interest was then added in its buffer of choice (here 0.1 M so-
dium bicarbonate, pH 8.3, for GFP, biotin-BSA, and Neu-
trAvidin) at 5 µg/ml and allowed to bind to the fibrinogen
anchor for 5 min before extensive washes and imaging. Alter-
natively, when proteins were directly micropatterned, the fi-
brinogen anchor in the above protocol was replaced by the
protein of interest at a concentration of 50 µg/ml in 0.1 M so-
dium bicarbonate, pH 8.3 (except for fluorescent EGF, where
biotinylated EGF complexed to streptavidin-Alexa555 [E35350;
Invitrogen] was patterned at 1 µg/ml in 0.1 M sodium bicar-
bonate, pH 8.3). After a 5-min incubation, the surface was
quenched and washed as above.
For sequential multiplexed micropatterning experiments on
PLL-PEG–passivated coverslips (Fig. 1, C–E; Fig. 3; and Fig. S1, D–F),
the protocol above was performed except that immediately after
the PEG quenching step, BBTB was added to the chamber (50 mM
in 0.1 M sodium bicarbonate, pH 8.3), and the whole process was
repeated for a second fibrinogen anchor (and a third time for the
triple patterning in Fig. 1, C–E). For Fig. 3, where fibrinogen
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anchors were used to subsequently bind to two proteins of interest,
said proteins of interest were added together aftermicropatterning
of both fibrinogen anchors (5 µg/ml each in 0.1 M sodium bicar-
bonate, pH 8.3, for 5min) before extensivewashes and imaging. All
fibrinogen anchors that are not fluorescent were doped with 5 µg/
ml fibrinogen-Alexa546 to image their respectivemicropattern and
thereby align the next micropattern. For controls where one fi-
brinogen anchor was omitted, it was replaced with fibrinogen-
Alexa546.
For dual micropatterning experiments where receptors
were clustered to micropatterns (Fig. 6, Fig. 7, and Fig. S5), the
above protocol was performed, with the small central region
micropatterned first (50 µg/ml GFP, fibrinogen-GFP, fibrin-
ogen-biotin-ATTO490LS, or fibrinogen-biotin-Alexa647), be-
fore PLL-PEG quenching and micropatterning of the second,
outer region (50 µg/ml fibronectin plus 10 µg/ml fibrinogen-
Alexa546 or fibrinogen-Alexa647). For relocalization of the
GBP-TM-mScarlet receptor, micropatterns (with a central fi-
brinogen-biotin-ATTO490LS center) were incubated (or not)
with streptavidin-GFP-GFP (10 µg/ml) and fixed with 0.5 mM
dithiobis(succinimidyl propionate) for 20 min. After exten-
sive washing, NIH/3T3 cells were added (20,000 cells/well) in
serum-free DMEM for 30 min before washing into medium
containing serum and imaging 30 min later. Alternatively, for
live imaging of GBP-TM-mScarlet recruitment (Fig. 6), 20,000
cells were added per well, in L15 plus 20 mM Hepes, and imaged
as they landed and spread on micropatterns. For relocalization of
EGFR and GFP-Notch1, double micropatterns were incubated
with NeutrAvidin (25 µg/ml) for 5 min before extensive washing
and incubation for 5 min with biotinylated-EGF (1 µg/ml) or
biotinylated-DLL4 (0.5 µM), respectively. Chambers were then
extensively washed. HeLa cells were serum starved for 24 h
before addition, in serum-free medium, to EGF micropatterns
(20,000 cells/well). Cells were left to spread for 40 min before
fixation. U2OS GFP-Notch1 cells, induced for 24 h to express
GFP-Notch1, were added to DLL4 micropatterns in L15 plus
20mMHepes (20,000 cells/well) and imaged as they landed and
spread on micropatterns.
For micropatterning of Kin1-biotin using the fibrinogen-bi-
otin::NeutrAvidin “sandwich” (Fig. 4), PLL-PEG–passivated
coverslips assembled into 8-well chambers were exposed for
90 s before the addition of fibrinogen-biotin-ATTO490LS (50
µg/ml in 0.1 M sodium bicarbonate, pH 8.3) as above. Micro-
patterns were then quenched with 0.5 mg/ml PLL-PEG for 5 min
before addition of NeutrAvidin (10 µg/ml in 0.1 M sodium bi-
carbonate, pH 8.3, for 5 min) before washing and incubation
with 5 µg/ml purified Kin1-biotin in 80 mM Pipes, 1 mMMgCl2,
and 5 mM ATP, pH 8.9, for 5 min. Alternatively, for direct mi-
cropatterning of Kin1-biotin, micropatterns were exposed to
micropatterned UV light in the presence of BBTB for 90 s as
above before addition of 5 µg/ml Kin1-biotin in 80 mM Pipes,
1 mM MgCl2, and 5 mM ATP, pH 8.9. Micropatterns were then
quenched with 0.5 mg/ml PLL-PEG for 5 min. 4 µl of GMPCPP
MT seeds (see above) were then added to each well, in 200 µl of
ATP-regenerating buffer (80 mM Pipes, 0.1 mg/ml κ-casein,
40 µMDTT, 64 µM glucose, 160 µg/ml glucose oxidase, 20 µg/ml
catalase, 0.1% methylcellulose, and 1 mM ATP, pH 6.9), and
imaged by TIRF microscopy. For direct micropatterning of Kin1-
biotin, visualization of micropatterns was performed after
imaging by addition of 1 µM streptavidin-Alexa647.
For micropatterning of Con A to bind to S2 cells (Fig. 5),
surface-activated coverslips were passivated with 0.1 mg/ml
PLL-PEG before being micropatterned using a quartz-chromium
photomask and a deep UV light source for 5 min as described
previously (Azioune et al., 2009). Exposed coverslips were then
incubated with 200 µl fibrinogen alone (50 µg/ml fibrinogen
and 5 µg/ml fibrinogen-Alexa546), Con A alone (50 µg/ml Con A
and 5 µg/ml rhodamine–Con A), or fibrinogen–Con A (50 µg/ml
fibrinogen–Con A and 5 µg/ml fibrinogen-Alexa546), all in 0.1 M
sodium bicarbonate, pH 8.3, for 1 h. Coverslips were washed in
0.1 M sodium bicarbonate, pH 8.3, and assembled into an 8-well
chamber. 100,000 S2 cells in low (1%) serum media were then
added to each well for 1 h before incubation with SiR-tubulin
(1 µM; Spirochrome; Lukinavičius et al., 2014) for 30min to label
cells. Chambers were washed with Schneider medium plus 10%
heat-inactivated FBS and imaged by confocal spinning-disc
microscopy.
For micropatterning on PEG-silane–passivated coverslips in a
flow cell configuration (Fig. S3), clean room–grade coverslips (75
× 25 mm; Nexterion) were surface-activated under pure oxygen
in a plasma cleaner and then incubated with PEG-silane (30 kD;
PSB-2014; Creative PEGWorks) at 1 mg/ml in ethanol 96%/0.1%
HCl overnight at RT with gentle agitation. Standard 22 × 22–mm
coverslips were similarly passivated with PEG-silane, omitting
the plasma-cleaning step. Slides and coverslips were then suc-
cessively washed in 96% ethanol and ultrapure water before
drying under nitrogen gas. The coverslip and slide were subse-
quently assembled into an array of six flow cells (∼15 µl each)
using double-sided tape (AR-90880; Adhesive Research; cut
with a Graphtec CE6000 cutting plotter). The flow cell chamber
was then filled with BBTB (50 mM in 0.1 M sodium bicarbonate,
pH 8.3) and exposed to UV light on the DMD-UV arm of the
micropatterningmicroscope (3-s exposure) after focusing on the
glass/buffer interface. The flow cell was subsequently washed
with three flow cell volumes of carbonate buffer, and fibrinogen-
biotin was then injected at 20 µg/ml in 0.1 M sodium bicar-
bonate, pH 8.3. After a 2-min incubation, the chamber was
washed with three flow cell volumes of carbonate buffer, and
NeutrAvidin (or NeutrAvidin-Dylight-550) was injected at
50 µg/ml in 0.1 M sodium bicarbonate, pH 8.3. The chamber
was then washed with Hepes buffer (10 mMHepes, pH 7.6) and
quenched with PLL-PEG (0.2 mg/ml in 10 mM Hepes, pH 7.6)
for 2 min. The chamber was then washed with Hepes buffer,
and BSA-biotin-Alexa647 was added (10 µg/ml in 10mMHepes,
pH 7.6) for 1 min, before extensive washing with Hepes buffer
before imaging. For controls where NeutrAvidin was directly
micropatterned, fibrinogen-biotin was replaced by NeutrAvidin/
NeutrAvidin-DyLyte550 (50 µg/ml in carbonate buffer), and the
chamber was directly washed with Hepes buffer, quenched with
PLL-PEG, and incubated with BSA-biotin-Alexa647 as above.
In general, we found that buffer composition (Fig. S1 B) and
avoiding drying of the surface (Fig. S4, A and B) were funda-
mental for ensuring reproducibility, selectivity, and homoge-
neity of micropatterning. Note that while the micropatterning
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buffer is important, the use of fibrinogen anchors allows one to
bind the proteins of interest to the micropattern in virtually any
buffer, as this binding step occurs after the micropatterning
process.
Image processing
Images were processed using Fiji (Schindelin et al., 2012). Fig-
ures were assembled in Adobe Illustrator 2019.
Patterning selectivity and homogeneity were computed as
follows per micropattern:
Selectivity  AvgIntensitypattern − Avgbackgroundcamera
AvgIntensitynotpattern − Avgbackgroundcamera
Homogeneity  AvgIntensitypattern − Avgbackgroundcameraffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
varIntensitypattern − varbackgroundcamera
p ,
with AvgIntensitypattern representing the average fluorescence intensity
of the fluorescent protein onto a micropatterned region of interest
(ROI) and its associated variance, varIntensitypattern; AvgIntensitynotpattern
representing the average fluorescence intensity of the fluorescent
protein onto a nonpatterned ROI adjacent to the micro-
pattern; and Avgbackgroundcamera representing the average
background intensity of the camera and its associated variance,
varbackgroundcamera.AvgIntensitypattern, AvgIntensitynotpattern, and
varIntensitypattern were measured in an ROI of identical size (and
as large as possible to provide good estimates). Avgbackgroundcamera
and varbackgroundcamera were obtained by measuring the signal in
the dark upon screwing a lid onto the camera. We verified that
PLL-PEG does not display any autofluorescence signal in the
conditions we used (in other words, the fluorescence intensity of
an unpatterned PLL-PEG coverslip that was never incubated with
any fluorescent protein is virtually identical to the camera
background).
Similarly, we measured a proxy of the amount of protein
specifically being deposited onto the micropatterned ROI as
follows:
Amount of protein patterned 
AvgIntensitypattern − AvgIntensitynotpattern
Note that while the Selectivity is a normalized value and can be
compared between fluorophores, the Amount of protein patterned is
only valid when comparing the same fluorophore, as it will also
depend on the photophysics of the dye and the sensitivity of the
instrument to the dye.
To evaluate the amount of cross-adsorption between micro-
patterns during sequential micropatterning of multiple fibri-
nogens (Fig. 1, C–E; and Fig. S1, D–F), we thought to express the
amounts of fibrinogens going to the wrong micropatterns as a
fraction of the amount going to the right micropattern. This al-
lows direct comparison between fibrinogens and gives a direct
idea of how much cross-contamination there is. For instance, in
Fig. 1, C–E, we sequentially micropatterned fibrinogen-
ATTO488, fibrinogen-Alexa546, and then fibrinogen-Alexa647.
We thus measured the fluorescence of each fibrinogen in all
threemicropatterns and normalized these values with respect to
the intended micropattern (i.e., since the order is [1] fibrinogen-
ATTO488, [2] fibrinogen-Alexa546, then [3] fibrinogen-Alexa647,
signals in the ATTO488 channel are normalized to micropattern 1,
Alexa546 to micropattern 2, and Alexa647 to micropattern 3). In
mathematical terms,
Normalized patterned Fibrinogen ATTO488pattern #i 
AvgIntensity488pattern #i − Avgbackground488coverslip
AvgIntensity488pattern #1 − Avgbackground488coverslip
Normalized patterned Fibrinogen Alexa546pattern #i 
AvgIntensity546pattern #i − Avgbackground546coverslip
AvgIntensity546pattern #2 − Avgbackground546coverslip
Normalized patterned Fibrinogen Alexa647pattern #i 
AvgIntensity647pattern #i − Avgbackground647coverslip
AvgIntensity647pattern #3 − Avgbackground647coverslip
,
with AvgIntensity488pattern #i (respectively, AvgIntensity
546
pattern #i and
AvgIntensity647pattern #i) the average fluorescence signal in the
ATTO488 channel in the micropatterned ROI (respectively, in




Avgbackground647coverslip) the average fluorescence background in
the ATTO488 channel (respectively, in the Alexa546 and
Alexa647 channels) measured on a PLL-PEG–coated coverslip
never exposed to UV or incubated with fluorescent fibrinogens.
As noted before, due to the absence of autofluorescence, this is
virtually identical to the background gray levels of the camera
(Avgbackgroundcamera ≈ Avgbackground488 / 546 /647coverslip ). As can be seen
in Fig. 1 E, cross-adsorption between the different micropatterns
is minimal: the amount of fibrinogen-Alexa546 wrongly going
onto the fibrinogen-ATTO488 micropattern is only 1.3 ±
0.05% (mean ± SEM; n = 12) of that of the amount of
fibrinogen-Alexa546 going to the intended, fibrinogen-Alexa546,
micropattern. Similarly, the amount of fibrinogen-Alexa647 going
to the wrong fibrinogen-ATTO488 micropattern (respectively,
fibrinogen-Alexa546) is only 0.7 ± 0.04% (respectively, 3.0 ± 0.3%;
n = 12) of the fibrinogen-Alexa647 going to the right fibrinogen-
Alexa647 micropattern. Similar results were obtained in sequen-
tial micropatterning of two (not three) fibrinogens (see Fig. S1 F,
where the graph scale has been split to better appreciate the
difference).
To evaluate the amount of fibrinogen binding nonspecifically
to unexposed PLL-PEG (Fig. S1 F), we computed the amounts of
fibrinogens found on the PLL-PEG coverslip as a fraction of
the amount going to the intended micropatterned region.
Specifically, in the fibrinogen-ATTO488/Alexa647 sequential
micropatterning experiment described above, we also mea-
sured the average ATTO488 and Alexa647 signals in ROIs
corresponding to unpatterned regions. Importantly, we
maintained the position of the ROIs in the field of view (that
is, we moved the sample to an area without micropatterns) in
order to account for any potential inhomogeneities in the il-
lumination of our microscope. Keeping the above nomencla-
ture, we thus evaluated
Normalized Fibrinogen ATTO488PLL−PEG 
AvgIntensity488PLL−PEG − Avgbackground488coverslip
AvgIntensity488pattern #1 − Avgbackground488coverslip
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Normalized Fibrinogen Alexa647PLL−PEG 
AvgIntensity647PLL−PEG − Avgbackground647coverslip
AvgIntensity647pattern #2 − Avgbackground647coverslip
,
with AvgIntensity488PLL−PEG the average fluorescence signal in the
ATTO488 channel in the same ROI used to measure
AvgIntensity488pattern #1 but in a region of the sample where there is
no micropattern (same thing for AvgIntensity647PLL−PEGand
AvgIntensity647pattern #2). As can be seen in Fig. S1 F, nonspecific
binding to the PLL-PEG coverslip is extremely low: the amount
of fibrinogen-ATTO488 wrongly going onto the nonmicropatterned
PLL-PEG is only 0.40 ± 0.06% (n = 8) that of the amount of
fibrinogen-ATTO488 going to its intended micropattern (respec-
tively, 0.66 ± 0.04% for fibrinogen-Alexa647; n = 8). This is in good
agreement with the fact that when the image dynamic range is
adjusted to see the minute signals on the PLL-PEG part, a punctate,
single molecule–like signal is observed (arrowheads in Fig. S1 E,
right panel).
The enrichment of mScarlet relocalization (Fig. 6 C) was
quantified as follows:
mScarlet enrichment in inner pattern 
AvgIntensity mScarlet in GFP pattern ROI − Avgbackgroundnon pattern
AvgIntensitymScarlet not in GFP pattern ROI − Avgbackgroundnon pattern ,
with AvgIntensity mScarlet in GFP pattern ROI representing the average
fluorescence intensity of mScarlet in the ROI corresponding to
the micropatterned GFP, and AvgIntensitymScarlet not in GFP pattern ROI
representing the average fluorescence intensity of mScarlet in
the ROI of the same size but corresponding to a ROI in the
fibronectin micropattern surrounding the GFP center.
Avgbackgroundnon pattern represents the mScarlet fluorescence
intensity in unpatterned regions of the coverslip.
The enrichment of EGFR and clathrin (Fig. 7 C) were calcu-
lated as follows:
Enrichment in center pattern 
AvgIntensity center pattern ROI − AvgIntensitycell−free center pattern ROI
AvgIntensitysurrounding ROI − AvgIntensitycell−free surrounding ROI ,
with AvgIntensitycenter pattern ROI representing the average fluo-
rescence intensity of EGFR/clathrin in the ROI corresponding to
the micropatterned EGF (where a cell is adhered to the micro-
pattern), AvgIntensitycell−free center pattern ROI representing the fluo-
rescence signal in a neighboring ROI corresponding to
micropatterned ligand (but without a cell adhered, to ac-
count for potential fluorescence bleed-through into the
imaging channel), AvgIntensitysurrounding ROI representing the
EGFR/clathrin signal in the fibronectin micropattern sur-
rounding the EGF center (where a cell is adhered), and
AvgIntensitycell−free surrounding ROI representing the fluorescence
intensity in a neighboring fibronectin micropattern without
a cell adhered (again, to account for any potential fluores-
cence bleed-through).
The fold enrichment of GFP-Notch1 (Fig. 7 F) was calculated
from live imaging of U2OS cells landing and spread on micro-
patterns, 20 min after landing on micropatterns, as follows:
Enrichment in center pattern 
AvgIntensity center pattern ROI 20 minutes − AvgIntensitycenter pattern ROI 0 minute
AvgIntensitysurrounding ROI 20 minutes − AvgIntensitysurrounding ROI 0 minute ,
where AvgIntensity center pattern ROI 20 minutes is the average fluorescence
intensity of GFP-Notch1 20 min after a cell landing on the micro-
pattern in the region corresponding to themicropatternedDLL4, and
AvgIntensitycenter pattern ROI 0 minutes represents the average fluorescence
intensity in the same region before the cell landing on the micro-
pattern (to account for any potential fluorescence bleed-through).
Similarly, AvgIntensitysurrounding ROI 20 minutes is the average fluorescence
intensity of GFP-Notch1 in the outermicropattern, 20min after a cell
lands on the micropattern, and AvgIntensitysurrounding ROI 0 minutes is the
average fluorescence intensity of the same region before a cell
landing on it.
To quantify the recruitment of GFP-Notch1 to DLL4 mi-
cropatterns over time (Fig. S5 E), the raw increase in GFP-
Notch1 signal overlying the central, DLL4 region compared
with the outer fibronectin micropattern was calculated (due
to relatively low signals, this is less volatile than the fold
change):
Increase of GFP − Notch signal in center pattern 
(AvgIntensity center pattern ROI − AvgIntensitycenter pattern ROI 0 minute)−
(AvgIntensity surrounding ROI − AvgIntensitysurrounding ROI 0 minute),
where AvgIntensity center pattern ROI is the average fluorescence in-
tensity of GFP-Notch1 in the central, DLL4 micropattern at the
specific time point, and AvgIntensitycenter pattern ROI 0 minutes repre-
sents the average fluorescence intensity in the central region
before a cell landing (to account for any potential fluorescence
bleed-through). AvgIntensity surrounding ROI is the average fluores-
cence intensity of GFP-Notch1 in the outer micropattern at the
same time point, and AvgIntensitysurrounding ROI 0 minutes is the aver-
age fluorescence intensity in the same region before a cell landing
on the micropattern (to account for potential bleed-through).
For analysis of MT gliding on Kin1-biotin micropatterns
(Fig. 4), movies were projected in time, and these projections
were used to define the path of gliding MTs, from which ky-
mographs were generated and analyzed using the “Kymo
Toolbox” plugin for ImageJ, developed by Fabrice Cordelières
(Zala et al., 2013). For analysis of the proportion of MTs un-
dergoing directional movement, MTs were manually seg-
mented based on whether or not they showed clear, directed
motion.
To quantify the increased micropatterning efficiency of S2
cells onto small micropatterns in Fig. 5, we computed the nor-
malized density of micropatterned cells as follows:










with nCellpattern representing the number of cells per micro-
pattern and Areapattern representing the area of the same mi-
cropatterns, and mean(nCellConApattern/AreaConApattern)the mean density of
the Con A sample. Only small micropatterns, of diameter 20–40
µm, were considered for analysis.
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To quantify the specificity of S2 cell adhesion, we computed
the normalized nonspecific adhesion (to micropatterns of be-
tween 20 and 40 µm in diameter) as follows:













Unless stated otherwise, measurements are given in mean ±
SEM. Statistical analyses were performed using GraphPad Prism
8 or SigmaStat 3.5 with an α of 0.05. Normality of variables was
verified with Kolmogorov–Smirnov tests. Homoscedasticity of
variables was always verified when conducting parametric tests.
Post hoc tests are indicated in their respective figure legends.
Online supplemental material
Fig. S1 shows fibrinogen micropatterning using LIMAP. Fig. S2
illustrates that fibrinogen is readily functionalized with target
proteins or ligands. Fig. S3 shows that fibrinogen anchors im-
prove selectivity and homogeneity of micropatterns on PEG-
silane surfaces. Fig. S4 displays the effect of sample drying on
micropatterning efficiency and improved micropatterning of S2
cells by fibrinogen anchors. Fig. S5 illustrates the dynamics and
controls of subcellular micropatterning of receptors. Video
1 shows that fibrinogen anchors facilitate micropatterning of
active motors. Video 2 demonstrates the dynamics of GBP-TM-
mScarlet relocalization by fibrinogen-GFP micropatterns.
Video 3 illustrates the dynamics of GFP-Notch relocalization
by fibrinogen-Delta micropatterns.
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Théry and Benoit Vianay for their extensive help in setting up
micropatterning in the laboratory at the beginning of this pro-
ject. We thank Laurent Blanchoin and Antoine Jegou for criti-
cally reading the manuscript. We thank the electronics workshop
of the Laboratory of Molecular Biology, in particular Martin Kyte,
for building custom LED drivers for this project. We thank the
technical instrumentation workshop of the Laboratory of Molec-
ular Biology, in particular Steve Scotcher and Adam Fowle, for
their help in designing and manufacturing the custom-made op-
tical mounts of the DMD illuminator. We thank Tino Pleiner and
Mark Allen for plasmids.
This work has been supported by the Medical Research Council
(MC_UP_1201/13 to E. Derivery) and the Human Frontier Science
Program (Career Development Award CDA00034/2017-C to E. De-
rivery). J.L. Watson is the recipient of a Michael Neuberger Stu-
dentship from theMax Perutz Fund and Trinity College, Cambridge.
S.C. Blacklow receives research funding for an unrelated
project from Novartis, is a member of the scientific advisory
board of Erasca, Inc., is an advisor to MPM Capital, and is a
consultant on unrelated projects for IFM, Scorpion Therapeu-
tics, and Ayala Therapeutics. The other authors declare no
competing financial interests.
Author contributions: J.L. Watson performed all micro-
patterning experiments except Fig. S3, which was performed by
S. Aich. J.L. Watson purified all proteins and fibrinogen anchors,
with some assistance from E. Derivery. E. Derivery developed the
LED illuminator with assistance from J.L. Watson and S. Aich. B.
Oller-Salvia, with support from J. Chin, developed the one-step
quantitative synthesis of the BBTB. A.A. Drabek and S.C. Black-
low provided the purified DLL4 protein and derived the GFP-
Notch1 U2OS cell line. J.L. Watson, S. Aich, and E. Derivery
produced the figures. E. Derivery wrote the manuscript. All
authors discussed the results and commented on themanuscript.
Submitted: 15 September 2020
Revised: 16 November 2020
Accepted: 23 November 2020
References
Aumeier, C., L. Schaedel, J. Gaillard, K. John, L. Blanchoin, and M. Théry.
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Figure S1. Fibrinogen micropatterning using LIMAP. (A) Optical design of the DMD-UV illuminator used in this study. Schematic optical path. A 385-nm
high-power UV LED light source is collimated using an AR-coated aspheric lens, and the collimated UV beam is then directed toward a DMD chip at a 24° angle
of incidence (corresponding to twice the tilting angle of the DMDmirrors). The image of the DMD chip is then relayed onto the conjugate of the sample plane at
the backport of the microscope through a 4f imaging system (f1 = f2 = 125 mm UV fused silica bi-convex lenses, AR-coated). This intermediate image is then
relayed onto the sample plane by a tube lens and the objective. To combine DMD-UV illumination with TIRF illumination, a 470-nm dichroic is placed after f2
within a custom backport assembly (Cairn). To offer a second illumination wavelength for 450-nm optogenetic stimulation, our design also contains a second
450-nm collimated LED at the symmetric −24° angle. This LED can be exchanged for any other LED to provide epifluorescence imaging. (B and C) Enhanced
fibrinogen micropatterning efficiency depends on the buffer used. (B) PLL-PEG–coated glass was processed for LIMAP patterning with identical UV exposure,
micropattern shape, and photoinitiator concentration (50 mM BBTB in 0.1 M sodium bicarbonate, pH 8.3). Fibrinogen-Alexa546 (50 µg/ml) was then adsorbed
onto the UV-activated surface in either PBS or carbonate buffer. After washing, red fluorescence of the patterns was imaged by TIRFM using identical settings.
(C)Quantification of the effects seen in B (average selectivity ± SEM; see Materials andmethods). Fibrinogen quantitatively patterns better in carbonate buffer.
Statistics were performed using a Mann–Whitney rank-sum test. n, number of patterns measured. (D–F) Advantages of fibrinogen for multiplexed micro-
patterning. (D) Scheme illustrating the different steps for sequential multiplexed micropatterning of two fibrinogens labeled with different fluorophores
(ATTO488 and Alexa647). (E) Multiplexed micropatterning of fibrinogen-ATTO488 and Alexa647 (50 µg/ml) using the scheme depicted in D onto PLL-
PEG–coated glass. Note that there is high specificity of the fibrinogen for their specific pattern and minimum overlap among the two fluorescent fibrinogens. In
addition, binding of fibrinogen to unexposed PLL-PEG is minimal, down to a punctate, single molecule–like level (orange arrowheads). (F) Quantification of the
effects seen in E: the fluorescence of each Fibrinogen was measured on the two patterns and normalized to the fluorescence of their intended pattern (i.e., first
pattern for Alexa647 and second for ATTO488; mean ± SEM). Statistics were performed using a Kruskal–Wallis test followed by a Dunn post hoc test (P <
0.0001). n, number of patterns measured. Note that the vertical scale of the graph is split to better appreciate the minute amounts of fibrinogen deposited onto
the nonintended patterns or the unpatterned PLL-PEG area. Scale bars, 10 µm. n.s., not significant.
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Figure S2. Fibrinogen is readily functionalizedwith target proteins or ligands. (A) General three-stepmethod to functionalize fibrinogen with a protein of
interest using lysine reactivity. Reactive thiols are generated onto fibrinogen, which are then reacted with the maleimide-functionalized protein of interest
(GFP, Con A, NeutrAvidin). Excess unreacted protein of interest is removed by differential native precipitation. (B) Two-step method to functionalize fibrinogen
if the protein/ligand of interest has reactive thiols (for example, nanobodies engineered with cysteines). (C) One-step method to functionalize fibrinogen with
an NHS derivative of a ligand of interest (biotin, fluorophores).
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Figure S3. Fibrinogen anchors improves selectivity and homogeneity ofmicropatterns on PEG-silane surfaces. (A)NeutrAvidin-DyLight-550 (50 µg/ml)
was micropatterned on PLL-PEG–coated glass using LIMAP. Alternatively, fibrinogen-biotin was micropatterned with identical UV exposure, pattern shape, and
protein concentration, followed by the addition of NeutrAvidin-Dylight-550 and imaging by TIRFM. (B) Quantification of amount of micropatterned protein
(left), pattern selectivity (middle), and homogeneity (right) in the sample presented in A (mean ± SEM). Statistics were performed using a Mann–Whitney test
for the left and right panels, and a Student’s t test for the middle panel. Fibrinogen-biotin significantly improves the micropatterning of NeutrAvidin-Dylight-
550. (C) NeutrAvidin, NeutrAvidin-Dylight-550, or fibrinogen-biotin were micropatterned on PEG-silane–coated glass using LIMAP with identical UV exposure,
pattern shape, and protein concentration (50 µg/ml). After pattern quenching and washing, BSA-biotin-Alexa647 (5 µg/ml) was added for 5 min. The sample
was then washed, and BSA-biotin-Alexa647 fluorescence was imaged by TIRFM (NeutrAvidin, NeutrAvidin-Dylight-550, and fibrinogen-biotin samples). Al-
ternatively, fibrinogen-biotin was micropatterned as above, and NeutrAvidin (or NeutrAvidin-Dylight-550) was added before addition of BSA-biotin-Alexa647
and TIRFM imaging. Two different exposures were used for each sample (top versus bottom line) so that each lane could be represented with the same
dynamic range. (D) Quantification of the amount of micropatterned protein (left), micropattern selectivity (middle), and homogeneity (right) in the sample
presented in C (mean ± SEM). Statistics were performed using a one-way ANOVA test followed by a Tukey post hoc test after log10 transformation of the data
(P < 0.001). Fibrinogen-biotin enhances significantly the amount of BSA-biotin-Alexa647 patterned, as well as pattern selectivity and homogeneity. While
fibrinogen-biotin efficiently improves the micropatterning of NeutrAvidin-Dylight-550 compared with direct micropatterning, this does not translate into
improved micropatterning of BSA-biotin-Alexa647, likely because NeutrAvidin-Dylight-550 has lost some biotin-binding activity due to its fluorescent labeling.
Scale bar, 10 µm. biot, biotin; n.s., not significant.
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Figure S4. Effect of sample drying on micropatterning efficiency and improved micropatterning of S2 cells by fibrinogen anchors. (A and B) Sample
drying during or after the micropatterning process affects micropatterning efficiency. (A) Drying of the pattern during or after the micropatterning process
negatively impacts the micropatterning efficiency. Left: PLL-PEG–coated glass was processed for LIMAP patterning of fibrinogen-GFP (50 µg/ml). Middle: After
imaging the pattern, the sample was dried, then rehydrated and imaged again in the same conditions. Right: PLL-PEG–coated glass was processed for LIMAP
patterning of fibrinogen-GFP as before, but the sample was allowed to dry after the adsorption process. Two different dynamic ranges for visualization were
used for each sample (top versus bottom line) so that each lane could be represented with the same dynamic range. (B) Protein adsorption to the non-
micropatterned region is also increased upon drying during/after the micropatterning process. Sample was treated as in A, but nonpatterned regions were
imaged. (C) Fibrinogen–Con A enhances the micropatterning of S2 cells. Con A (doped with 10% rhodamine–Con A) or fibrinogen–Con A (doped with 10%
fibrinogen–Alexa546) was micropatterned at 50 µg/ml onto PLL-PEG–coated glass using deep UV and a chromiummask. Coverslips were washed, and S2 cells
were added for 1 h before addition of SiR-tubulin, to label cells, for 30 min. After washing, cells and micropatterns were imaged by spinning-disc confocal
microscopy. Micropatterning efficiency of S2 cells is lower on Con A compared with fibrinogen–Con A. Dashed line, region exposed to deep UV. Scale bars, 10
µm (A and B), and 100 µm (C).
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Figure S5. Dynamics and controls of subcellular micropatterning of receptors. (A–C) Regular micropatterning does not allow subcellular micropatterning
of receptors. (A) Experimental scheme. Stable NIH/3T3 cells constitutively expressing GBP-TM-mScarlet were allowed to spread on dual patterns of fibro-
nectin/fibrinogen-Alexa647 and either GFP, fibrinogen-GFP (low degree of labeling of 0.5 mol GFP per mol fibrinogen), or fibrinogen-biotin::streptavidin-GFP-
GFP, then imaged live by TIRF microscopy. (B) Only high-density GFP micropatterning via fibrinogen-biotin::streptavidin-GFP-GFP allows efficient relocali-
zation of the GBP-TM-mScarlet construct onto an area defined by the extracellular pattern. Note that bottom panel corresponds to Fig. 6 B, reproduced here
for convenience. Note also that the dynamic range of the GFP channel panels is not identical here. There is much more GFP when using streptavidin-GFP-GFP
compared with using fibrinogen-GFP. (C) In contrast to when biotin-EGF was attached to the fibrinogen-biotin-ATTO490LS::NeutrAvidin sandwich (Fig. 7,
A–C), direct micropatterning of biotin-EGF::streptavidin-Alexa555 (1 µg/ml) showed very weak, inhomogeneous, and nonspecific micropatterning, preventing
micropatterning of the second, surrounding fibronectin pattern. Dashed line, region exposed to UV. (D and E) Dynamics of GFP-Notch relocalization by Delta
micropatterns. (D) U2OS cells stably expressing GFP-Notch1 were allowed to spread on dual patterns of fibronectin/fibrinogen-Alexa647 and fibrinogen-biotin-
ATTO490LS::NeutrAvidin::biotin-DLL4 and GFP-Notch fluorescence was imaged live during spreading by TIRF microscopy. Elapsed time in minutes:seconds.
(E)Quantification of the effects seen in D (mean ± SEM; number of cells analyzed: 27 for control and 28 for Biotin-DLL4); see also Materials and methods. Scale
bars, 10 µm. Fib, fibrinogen; biot, biotin.
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Video 1. Fibrinogen anchors facilitate micropatterning of active motors. Biotinylated-Kinesin1 motors (Kin1-Biotin) were micropatterned on PLL-
PEG–coated glass using LIMAP either directly or indirectly through a fibrinogen-biotin-ATTO490LS::NeutrAvidin sandwich. After washing and quenching,
GMPCPP-stabilized fluorescent MTs were added in the presence of ATP and their motion observed by TIRFM. Dashed purple line delineates the kinesin pattern
as imaged either through post-labeling of Kin1-Biotin by streptavidin-Alexa647 for direct micropatterning or by fibrinogen-biotin-ATTO490LS fluorescence for
the indirect labeling. This movie corresponds to Fig. 4. Scale bar, 10 µm. sec, seconds. Playback speed: 30 frames per second.
Video 2. Dynamics of GBP-TM-mScarlet relocalization by fibrinogen-GFP micropatterns. NIH/3T3 cells stably expressing GBP-TM-mScarlet were al-
lowed to spread on dual micropatterns of fibronectin/fibrinogen-Alexa647 and fibrinogen-biotin-ATTO490LS::streptavidin-GFP-GFP and were then imaged
live by TIRF microscopy. Elapsed time in minutes. This movie corresponds to Fig. 6 D. Scale bar, 10 µm. Playback speed: 10 frames per second.
Video 3. Dynamics of GFP-Notch relocalization by fibrinogen-Delta micropatterns. U2OS cells stably expressing GFP-Notch1 were allowed to spread on
dual micropatterns of fibronectin/fibrinogen-Alexa647 and fibrinogen-biotin-ATTO490LS::NeutrAvidin::biotin-DLL4 (see Fig. 7, D and E), and GFP-Notch
fluorescence was imaged live during spreading by TIRF microscopy. Elapsed time in minutes. This movie corresponds to Fig. S5 D. Scale bar, 10 µm. Play-
back speed: 10 frames per second.
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